Exhibit A: Statement of Fees and Expenses by Subject Matter — Vyaire Medical Inc. (Case 24-11217-BLS Doc 823-2)
What This Document Is
A 95-page Exhibit A to Kirkland & Ellis's Fifth Monthly Fee Application (Docket 823), filed 2024-12-06, breaking October 2024's $1,013,776.00 in requested fees down by numbered "matter" category, followed (based on the exhibit's length relative to its one-page summary table) by detailed underlying time entries.
Factual Summary
The summary table (page 1) allocates 704.90 total billed hours and $1,013,776.00 in total fees across 11 matter categories, the largest being Matter 10, "Asset Sales/Section 363 Issues: Use, Sale..." at 411.30 hours / $609,876.00 (over 60% of the month's total K&E fees), followed by Matter 20, "Tax Matters" (104.60 hours / $150,356.00), Matter 6, "Disclosure Statement/Plan/Confirmation" (47.90 hours / $63,678.50), and Matter 22, "Retention - K&E" (45.00 hours / $52,661.50). Smaller categories include Corporate & Governance (37.80 hrs / $44,407.00), Insurance and Surety Matters (20.00 hrs / $36,987.50), Business Operations (19.10 hrs / $30,992.50), Case Administration (9.90 hrs / $12,220.50), DIP Financing and Cash Collateral (7.60 hrs / $10,791.00), Cash Management (1.20 hrs / $1,170.00), and Executory Contracts & Unexpired Leases (0.50 hrs / $635.50). No expenses are itemized in this exhibit (all "N/A" under Total Expenses Requested), consistent with expenses being tracked separately per the main application.
Key Facts
- Filed as an attachment to Docket 823, 2024-12-06, 95 pages; page 1 is the matter-category summary table, totaling 704.90 hours / $1,013,776.00.
- Dominant matter category for October 2024: Asset Sales/Section 363 Issues, 411.30 hours / $609,876.00 — roughly 60% of the month's K&E fee total, consistent with the Trudell/Zoll sale-transaction activity documented elsewhere in this docket range around this period.
- Second-largest category: Tax Matters, 104.60 hours / $150,356.00.
- This exhibit shows no expense line items (all N/A); expenses are handled separately in the main application (Docket 823).
Source Caveats
- Only the page-1 matter-category summary table was extracted here; the remaining ~94 pages (presumably line-item time entries underlying each matter category) were not individually transcribed in this pass.
- Date
- 2024-12-06
Cite this document
“Exhibit A: Statement of Fees and Expenses by Subject Matter — Vyaire Medical Inc. (Case 24-11217-BLS Doc 823-2).”
Original at ecf.deb.uscourts.gov, dated 2024-12-06. Archived at Pandemic Darlings, https://pandemicdarlings.com/source-documents/2024-12-06-gov-uscourts-deb-193283-823-2/
, SHA-256 a74a4047929dfc646acd825d89f3a8313f3a5861c2f3f7796880444dc4a6233e.Full text
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 1 of 95
EXHIBIT A
Statement of Fees and Expenses by Subject Matter
Total Total
Matter Total Fees Total
Matter Description Billed Expenses
Number Requested Compensation
Hours Requested
5 Corporate & Governance Matters 37.80 $44,407.00 N/A $44,407.00
Disclosure N/A
6 Statement/Plan/Confirmation 47.90 $63,678.50 $63,678.50
7 DIP Financing and Cash Collateral 7.60 $10,791.00 N/A $10,791.00
8 Cash Management 1.20 $1,170.00 N/A $1,170.00
Asset Sales/Section 363 Issues: Use, N/A
10 Sal 411.30 $609,876.00 $609,876.00
Executory Contracts & Unexpired N/A
11 Leases 0.50 $635.50 $635.50
12 Business Operations 19.10 $30,992.50 N/A $30,992.50
18 Insurance and Surety Matters 20.00 $36,987.50 N/A $36,987.50
20 Tax Matters 104.60 $150,356.00 N/A $150,356.00
21 Case Administration 9.90 $12,220.50 N/A $12,220.50
22 Retention - K&E 45.00 $52,661.50 N/A $52,661.50
Totals: 704.90 $1,013,776.00 N/A $1,013,776.00
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 2 of 95
EXHIBIT B
Attorneys and Paraprofessionals’ Information
The K&E attorneys who rendered professional services in these cases during the
Fee Period are:
Hourly
Date of Hours Billed Fees Billed
Billing Rate
Attorney Name Position Department Admissi In this In this
on In this
Application Application
Application
Chris Ceresa Associate Restructuring 2020 $1,395.00 17.10 $23,854.50
Tiffani Chanroo Associate Restructuring 2021 $1,345.00 23.70 $31,876.50
Corporate -
Luke Finn Associate M&A/Private 2021 $1,345.00 106.10 $142,704.50
Equity
Justin M. Technology & IP
Associate 2022 $1,095.00 8.00 $8,760.00
Garfinkle Transactions
Emanuel Goetz Associate Taxation 2024 $750.00 16.20 $12,150.00
Palmer
Associate Taxation 2023 $995.00 37.70 $37,511.50
Gunderson
Sabrina
Associate Restructuring 2023 $975.00 35.50 $34,612.50
Lieberman
Corporate -
Ruan J. Meintjes Associate 2022 $1,095.00 5.20 $5,694.00
Healthcare
Corporate -
Trent Nachbar Associate M&A/Private 2022 $1,265.00 0.20 $253.00
Equity
Corporate -
Dan O'Connor Associate M&A/Private 2021 $1,345.00 23.70 $31,876.50
Equity
Carolin Paus Associate Restructuring 2023 $750.00 36.70 $27,525.00
Joshua Raphael Associate Restructuring 2023 $1,095.00 0.90 $985.50
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 3 of 95
Hourly
Date of Hours Billed Fees Billed
Billing Rate
Attorney Name Position Department Admissi In this In this
on In this
Application Application
Application
Adrian Salmen Associate Restructuring 2021 $1,265.00 0.90 $1,138.50
Donatus Wang Associate Restructuring 2022 $960.00 20.20 $19,392.00
Corporate -
Ali Mohammad
Associate M&A/Private 2022 $1,095.00 7.60 $8,322.00
Zarrabi
Equity
Corporate -
Hendrik Braun Partner M&A/Private 2010 $1,145.00 3.00 $3,435.00
Equity
Bernadette Technology & IP
Partner 2013 $1,575.00 7.90 $12,442.50
Coppola Transactions
Hannah
Partner Restructuring 2015 $1,595.00 15.30 $24,403.50
Crawford
Anthony M. Del Corporate -
Partner 2014 $1,595.00 2.10 $3,349.50
Rio Healthcare
Michael Ehret Partner Taxation 2001 $1,895.00 56.20 $106,499.00
Susan D. Golden Partner Restructuring 1988 $1,600.00 0.50 $800.00
Corporate -
Kate Hardey Partner 2003 $1,995.00 9.90 $19,750.50
Healthcare
Corporate -
Maximilian Liegl Partner M&A/Private 2017 $1,070.00 1.00 $1,070.00
Equity
Corporate - Debt
Sean McClay Partner 2018 $1,575.00 3.20 $5,040.00
Finance
Litigation -
William T. Pruitt Partner 2009 $1,695.00 1.70 $2,881.50
General
Yusuf Salloum Partner Restructuring 2018 $1,595.00 61.30 $97,773.50
Corporate - Capital
Anna Schwander Partner 2002 $1,315.00 1.10 $1,446.50
Markets
Scottie Technology & IP
Partner 2018 $1,575.00 17.50 $27,562.50
Shermetaro Transactions
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 4 of 95
Hourly
Date of Hours Billed Fees Billed
Billing Rate
Attorney Name Position Department Admissi In this In this
on In this
Application Application
Application
Josh Sussberg,
Partner Restructuring 2004 $2,305.00 0.20 $461.00
P.C.
Corporate -
Steve Toth Partner M&A/Private 2005 $1,820.00 125.50 $228,410.00
Equity
Nicholas Warther Partner Taxation 2017 $1,665.00 16.20 $26,973.00
Cristina Weidner Partner Restructuring 2005 $1,665.00 18.60 $30,969.00
Spencer A.
Partner Restructuring 2013 $1,685.00 7.80 $13,143.00
Winters, P.C.
Sara B.
Partner Taxation 2003 $2,445.00 5.90 $14,425.50
Zablotney, P.C.
Ann-Kathrin
Partner Restructuring 2018 $1,070.00 3.20 $3,424.00
Ziegler
Totals 697.80 $1,010,915.50
The paraprofessionals of K&E who rendered professionals services in these cases during
the Fee Period are:
Hourly
Hours Billed Fees Billed
Billing Rate
Professional Name Position Department In this In this
In this
Application Application
Application
Junior Litigation -
Stephanie Choi $355.00 1.20 $426.00
Paralegal General
Junior
Tanzila Zomo Restructuring $355.00 3.90 $1,384.50
Paralegal
Amy Donahue Paralegal Restructuring $525.00 2.00 $1,050.00
Totals 7.10 $2,860.50
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 5 of 95
EXHIBIT C
Summary of Actual and Necessary Expenses for the Fee Period
Service Description Amount
Standard Copies or Prints $16.30
Color Copies or Prints $50.60
Local Transportation $254.13
Travel Expense $360.80
Airfare $1,556.62
Transportation to/from airport $324.35
Travel Meals $178.00
Outside Retrieval Service $1.83
Computer Database Research $23.76
Westlaw Research $729.90
LexisNexis Research $131.05
Overtime Transportation $234.22
Overtime Meals - Attorney $95.87
Total $3,957.43
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 6 of 95
EXHIBIT D
Detailed Description of Fees, Expenses, and Disbursements
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 7 of 95
601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
December 6, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050108822
Client Matter: 48520-5
In the Matter of Corporate & Governance Matters
For legal services rendered through October 31, 2024
(see attached Description of Legal Services for detail) $ 44,407.00
Total legal services rendered $ 44,407.00
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 8 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108822
Vyaire Medical Inc. Matter Number: 48520-5
Corporate & Governance Matters
Summary of Hours Billed
Name Hours Rate Amount
Chris Ceresa 2.50 1,395.00 3,487.50
Michael Ehret 0.30 1,895.00 568.50
Luke Finn 0.30 1,345.00 403.50
Emanuel Goetz 0.90 750.00 675.00
Sabrina Lieberman 3.00 975.00 2,925.00
Carolin Paus 10.80 750.00 8,100.00
Donatus Wang 3.30 960.00 3,168.00
Cristina Weidner 11.40 1,665.00 18,981.00
Spencer A. Winters, P.C. 0.50 1,685.00 842.50
Ali Mohammad Zarrabi 4.80 1,095.00 5,256.00
TOTALS 37.80 $ 44,407.00
2
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 9 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108822
Vyaire Medical Inc. Matter Number: 48520-5
Corporate & Governance Matters
Description of Legal Services
Date Name Hours Description
07/10/24 Cristina Weidner 0.50 Attend MIM winddown discussion.
08/06/24 Cristina Weidner 1.50 Telephone conference with A. Ziegler, K&E
team re sale process and tax structure (.3);
correspond with A. Ziegler and K&E team re
same (1.2).
08/16/24 Cristina Weidner 1.00 Attend update telephone conference and
follow up with team.
10/01/24 Carolin Paus 5.60 Coordinate with German notary re required
proof of representation for PoAs (.4); research
issues re shareholder resolutions (1.1); draft
shareholder resolutions for MIM and Vyaire
GmbH (2.9); draft comprehensive workstream
summary (1.2).
10/02/24 Donatus Wang 2.10 Revise draft PoAs for transfer of MIM,
GmbH (1.0); coordinate US notarization of
PoAs (1.1).
10/03/24 Chris Ceresa 0.20 Revise minutes re special committee meeting.
10/03/24 Sabrina Lieberman 0.10 Correspond with H. Crawford, K&E team re
Italian board composition.
10/04/24 Luke Finn 0.30 Prepare Vyaire shareholder resolutions via
DocuSign.
10/04/24 Donatus Wang 0.20 Review, analyze draft shareholder resolution
re approval of asset transfers by MIM and
Vyaire GmbH (.1); revise same (.1).
10/04/24 Cristina Weidner 0.60 Correspond with Company re German
documentation issues.
10/06/24 Chris Ceresa 0.20 Correspond with Company re corporate legal
issues.
10/06/24 Sabrina Lieberman 0.10 Correspond with Company, C. Ceresa re non-
US local counsel.
10/06/24 Cristina Weidner 2.50 Correspond with Company re German
documentation.
10/07/24 Chris Ceresa 0.80 Correspond with Y. Salloum and K&E team
re corporate issues (.3); draft and revise
special committee minutes (.5).
10/07/24 Carolin Paus 5.20 Draft executed versions of shareholder
resolutions (.4); draft share transfer agreement
for transfer of Vyaire medical GmbH (3.9);
coordinate registration of Vyaire Medical Inc.
with German transparency register (.9).
3
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 10 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108822
Vyaire Medical Inc. Matter Number: 48520-5
Corporate & Governance Matters
Date Name Hours Description
10/08/24 Donatus Wang 1.00 Correspond with Company and German
notary re KYC items, notarization of PoA and
secretary certificates.
10/09/24 Chris Ceresa 0.20 Correspond with Company re corporate
issues.
10/10/24 Chris Ceresa 0.70 Draft minutes re special committee meeting.
10/14/24 Sabrina Lieberman 0.10 Correspond with J. Mudhar, Cole Schotz re
international local counsel invoices.
10/16/24 Sabrina Lieberman 0.20 Conference with C. Ceresa re special
committee meeting.
10/17/24 Sabrina Lieberman 0.70 Draft special committee meeting minutes.
10/20/24 Sabrina Lieberman 0.10 Correspond with Company re Swiss auditor
documents.
10/21/24 Sabrina Lieberman 0.20 Correspond with C. Ceresa re special
committee meeting minutes.
10/22/24 Sabrina Lieberman 0.10 Correspond with Y. Salloum, AlixPartners re
Dutch counsel.
10/23/24 Chris Ceresa 0.20 Correspond with S. Lieberman re issues re
special committee meeting.
10/23/24 Michael Ehret 0.30 Analyze shareholder resolution.
10/23/24 Emanuel Goetz 0.40 Review and revise contemplated shareholders
resolution for Vyaire Medical GmbH.
10/23/24 Cristina Weidner 1.00 Telephone conference with A. Ziegler, K&E
team re shareholder resolution (.8); review,
analyze notes in preparation for same (.2).
10/24/24 Emanuel Goetz 0.50 Review and revise shareholder resolution.
10/24/24 Sabrina Lieberman 0.50 Draft special committee meeting minutes.
10/24/24 Cristina Weidner 1.00 Correspond with A. Ziegler, K&E team re
shareholder resolution and management
representation.
10/30/24 Cristina Weidner 1.00 Review, analyze SPA (.6); correspond with C.
Weidner re same (.4).
10/31/24 Chris Ceresa 0.20 Analyze, review status of corporate items.
10/31/24 Sabrina Lieberman 0.90 Conference with Y. Salloum re shareholder
meeting minutes (.1); draft special committee
meeting minutes (.3); draft shareholder
meeting minutes (.5).
10/31/24 Cristina Weidner 2.30 Draft comments to SPA (1.0); telephone
conference with C. Weidner re set-off
mechanism and intra-group positions (1.3).
4
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 11 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108822
Vyaire Medical Inc. Matter Number: 48520-5
Corporate & Governance Matters
Date Name Hours Description
10/31/24 Spencer A. Winters, P.C. 0.50 Prepare for SC meeting (.3); participate in SC
meeting (.2).
10/31/24 Ali Mohammad Zarrabi 4.80 Draft APA amendment, board and
shareholder resolutions re sale of Italian and
Australian subsidiaries (2.8); prepare officer
certificates (1.0); review, analyze checklist re
same (.5); analyze correspondence re same
(.5).
Total 37.80
5
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 12 of 95
601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
December 6, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050108823
Client Matter: 48520-6
In the Matter of Disclosure Statement/Plan/Confirmation
For legal services rendered through October 31, 2024
(see attached Description of Legal Services for detail) $ 63,678.50
Total legal services rendered $ 63,678.50
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 13 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108823
Vyaire Medical Inc. Matter Number: 48520-6
Disclosure Statement/Plan/Confirmation
Summary of Hours Billed
Name Hours Rate Amount
Chris Ceresa 0.30 1,395.00 418.50
Tiffani Chanroo 8.60 1,345.00 11,567.00
Stephanie Choi 1.20 355.00 426.00
Amy Donahue 2.00 525.00 1,050.00
Palmer Gunderson 3.40 995.00 3,383.00
Sabrina Lieberman 4.60 975.00 4,485.00
Yusuf Salloum 24.70 1,595.00 39,396.50
Nicholas Warther 0.50 1,665.00 832.50
Spencer A. Winters, P.C. 0.90 1,685.00 1,516.50
Tanzila Zomo 1.70 355.00 603.50
TOTALS 47.90 $ 63,678.50
2
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 14 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108823
Vyaire Medical Inc. Matter Number: 48520-6
Disclosure Statement/Plan/Confirmation
Description of Legal Services
Date Name Hours Description
10/01/24 Tiffani Chanroo 0.20 Correspond with Company re disclosure
statement.
10/02/24 Tiffani Chanroo 0.90 Review, revise combined hearing notice (.7);
correspond with Cole Schotz team re same
(.2).
10/03/24 Tiffani Chanroo 0.20 Correspond with Cole Schotz team re cover
letter.
10/07/24 Stephanie Choi 0.20 Transfer final set of documents re objections
and responses to UCC's requests.
10/08/24 Chris Ceresa 0.30 Review, revise disclosure statement notices
(.2); correspond with Cole Schotz team re
same (.1).
10/14/24 Stephanie Choi 0.50 Transfer produced documents for UCC.
10/15/24 Stephanie Choi 0.50 Compile and transfer produced documents re
UCC requests and interrogatories.
10/16/24 Yusuf Salloum 1.50 Prepare for confirmation.
10/18/24 Sabrina Lieberman 0.60 Conference with Y. Salloum, K&E team,
AlixPartners, UCC re work in process (.5);
correspond with UCC re same (.1).
10/18/24 Yusuf Salloum 1.00 Prepare for confirmation.
10/21/24 Amy Donahue 1.50 Research and pull plan supplement precedent
for S. Lieberman.
10/21/24 Sabrina Lieberman 0.50 Correspond with Y. Salloum, K&E team,
Cole Schotz re plan supplement.
10/22/24 Sabrina Lieberman 0.20 Telephone conference with P. Gunderson re
plan supplement.
10/22/24 Yusuf Salloum 2.40 Review, analyze issues re confirmation.
10/23/24 Sabrina Lieberman 0.80 Review, revise retained causes of action list
(.5); conference with Y. Salloum re same (.1);
correspond with Cole Schotz, Y. Salloum re
chapter 11 plan (.2).
10/23/24 Yusuf Salloum 2.50 Prepare for confirmation.
10/24/24 Sabrina Lieberman 0.20 Correspond with Y. Salloum, Cole Schotz re
chapter 11 plan.
10/24/24 Sabrina Lieberman 0.80 Review, revise counterproposal to UCC
settlement proposal (.6); correspond with Y.
Salloum, AlixPartners re same (.2).
10/24/24 Yusuf Salloum 2.50 Prepare for plan confirmation.
3
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 15 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108823
Vyaire Medical Inc. Matter Number: 48520-6
Disclosure Statement/Plan/Confirmation
Date Name Hours Description
10/24/24 Spencer A. Winters, P.C. 0.90 Review and analyze issues re UCC settlement
proposal (.4); participate in telephone
conference with special committee re same
(.3); prepare for same (.2).
10/25/24 Palmer Gunderson 2.30 Prepare draft restructuring transactions
memorandum.
10/25/24 Yusuf Salloum 2.30 Prepare for confirmation.
10/26/24 Nicholas Warther 0.50 Review and revise wind-down memorandum.
10/27/24 Palmer Gunderson 0.30 Review, analyze revisions to restructuring
transaction memorandum.
10/27/24 Yusuf Salloum 1.40 Prepare for confirmation.
10/28/24 Palmer Gunderson 0.80 Revise comments on restructuring
transactions memorandum.
10/28/24 Sabrina Lieberman 0.30 Correspond with Y. Salloum, K&E team,
Cole Schotz re plan supplement.
10/28/24 Yusuf Salloum 2.50 Analyze issues re confirmation.
10/29/24 Yusuf Salloum 2.70 Prepare for confirmation hearing.
10/30/24 Tiffani Chanroo 1.00 Conference with S. Lieberman, K&E team re
confirmation brief (.4); review, analyze issues
re same (.6).
10/30/24 Amy Donahue 0.50 Research and pull confirmation brief
precedent for S. Lieberman.
10/30/24 Sabrina Lieberman 0.80 Conference with T. Chanroo, K&E team re
confirmation brief (.5); review, analyze
confirmation brief (.3).
10/30/24 Yusuf Salloum 3.60 Prepare for confirmation.
10/31/24 Tiffani Chanroo 6.30 Review, revise confirmation brief (3.9);
review, analyze materials re same (2.4).
10/31/24 Sabrina Lieberman 0.40 Correspond with T. Chanroo, K&E team re
confirmation brief.
10/31/24 Yusuf Salloum 2.30 Prepare for confirmation hearing.
10/31/24 Tanzila Zomo 1.70 Research confirmation briefs re confirmation
analysis (1.2); research logistics re upcoming
hearings (.5).
Total 47.90
4
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 16 of 95
601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
December 6, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050108824
Client Matter: 48520-7
In the Matter of DIP Financing and Cash Collateral
For legal services rendered through October 31, 2024
(see attached Description of Legal Services for detail) $ 10,791.00
Total legal services rendered $ 10,791.00
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 17 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108824
Vyaire Medical Inc. Matter Number: 48520-7
DIP Financing and Cash Collateral
Summary of Hours Billed
Name Hours Rate Amount
Chris Ceresa 2.60 1,395.00 3,627.00
Sean McClay 3.20 1,575.00 5,040.00
Joshua Raphael 0.90 1,095.00 985.50
Adrian Salmen 0.90 1,265.00 1,138.50
TOTALS 7.60 $ 10,791.00
2
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 18 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108824
Vyaire Medical Inc. Matter Number: 48520-7
DIP Financing and Cash Collateral
Description of Legal Services
Date Name Hours Description
10/02/24 Chris Ceresa 0.20 Review draft DIP reporting (.1); correspond
with J. Raphael re same (.1).
10/04/24 Chris Ceresa 0.20 Review draft DIP reporting (.1); correspond
with J. Raphael re same (.1).
10/08/24 Sean McClay 3.00 Draft forbearance agreement re DIP loan
agreement maturity.
10/09/24 Chris Ceresa 0.20 Review draft DIP reporting (.1); correspond
with J. Raphael re same (.1).
10/09/24 Adrian Salmen 0.30 Correspond with C. Ceresa, K&E team re
professional fees.
10/10/24 Chris Ceresa 0.50 Review, analyze legal issues re DIP
forbearance agreement (.4); correspond with
Y. Salloum and K&E team re same (.1).
10/10/24 Joshua Raphael 0.30 Prepare signature pages re DIP forbearance
agreement (.2); correspond with Y. Han, C.
Ceresa re forbearance agreement (.1).
10/11/24 Chris Ceresa 0.20 Review draft DIP reporting (.1); correspond
with J. Raphael re same (.1).
10/11/24 Chris Ceresa 0.40 Review, analyze legal issues re DIP
forbearance agreement (.3); correspond with
Y. Salloum and K&E team re same (.1).
10/11/24 Joshua Raphael 0.10 Compile, analyze variance report.
10/11/24 Joshua Raphael 0.30 Prepare signature pages for forbearance
agreement (.2); correspond with C. Ceresa,
K&E team, Company re same (.1).
10/14/24 Chris Ceresa 0.20 Correspond with Y. Salloum and K&E team
re DIP forbearance issues.
10/14/24 Sean McClay 0.20 Review, analyze comments to DIP
forbearance agreement.
10/15/24 Chris Ceresa 0.30 Correspond with Y. Salloum and K&E team
re DIP forbearance issues.
10/16/24 Chris Ceresa 0.20 Correspond with Y. Salloum and K&E team
re DIP forbearance issues.
10/16/24 Adrian Salmen 0.30 Correspond with C. Ceresa, K&E team,
lender advisors re professional fees.
10/18/24 Chris Ceresa 0.20 Correspond with Y. Salloum and K&E team
re DIP forbearance issues.
10/18/24 Joshua Raphael 0.20 Prepare DIP variances report (.1); correspond
with AlixPartners re fees (.1).
3
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 19 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108824
Vyaire Medical Inc. Matter Number: 48520-7
DIP Financing and Cash Collateral
Date Name Hours Description
10/23/24 Adrian Salmen 0.30 Correspond with C. Ceresa, K&E team,
AlixPartners, lender advisors re professional
fees.
Total 7.60
4
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 20 of 95
601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
December 6, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050108825
Client Matter: 48520-8
In the Matter of Cash Management
For legal services rendered through October 31, 2024
(see attached Description of Legal Services for detail) $ 1,170.00
Total legal services rendered $ 1,170.00
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 21 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108825
Vyaire Medical Inc. Matter Number: 48520-8
Cash Management
Summary of Hours Billed
Name Hours Rate Amount
Sabrina Lieberman 1.20 975.00 1,170.00
TOTALS 1.20 $ 1,170.00
2
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 22 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108825
Vyaire Medical Inc. Matter Number: 48520-8
Cash Management
Description of Legal Services
Date Name Hours Description
10/02/24 Sabrina Lieberman 0.20 Correspond with C. Ceresa, JP Morgan re
Indian bank account.
10/03/24 Sabrina Lieberman 0.30 Conference with JP Morgan re India bank
account.
10/04/24 Sabrina Lieberman 0.50 Telephone conference with Cole Schotz re
Indian bank account (.1); telephone
conference with Company re same (.3);
correspond with C. Ceresa, K&E team, Cole
Schotz, Company re same (.1).
10/10/24 Sabrina Lieberman 0.10 Correspond with Company, JP Morgan re
Indian entity.
10/15/24 Sabrina Lieberman 0.10 Correspond with JP Morgan, Company re
India bank account.
Total 1.20
3
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 23 of 95
601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
December 6, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050108826
Client Matter: 48520-10
In the Matter of Asset Sales/Section 363 Issues: Use, Sale & Disposition of Property
For legal services rendered through October 31, 2024
(see attached Description of Legal Services for detail) $ 609,876.00
Total legal services rendered $ 609,876.00
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 24 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108826
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Summary of Hours Billed
Name Hours Rate Amount
Hendrik Braun 3.00 1,145.00 3,435.00
Chris Ceresa 1.80 1,395.00 2,511.00
Bernadette Coppola 7.90 1,575.00 12,442.50
Hannah Crawford 0.20 1,595.00 319.00
Anthony M. Del Rio 2.10 1,595.00 3,349.50
Michael Ehret 4.50 1,895.00 8,527.50
Luke Finn 105.80 1,345.00 142,301.00
Justin M. Garfinkle 8.00 1,095.00 8,760.00
Palmer Gunderson 1.20 995.00 1,194.00
Kate Hardey 7.40 1,995.00 14,763.00
Sabrina Lieberman 1.60 975.00 1,560.00
Maximilian Liegl 1.00 1,070.00 1,070.00
Ruan J. Meintjes 5.20 1,095.00 5,694.00
Trent Nachbar 0.20 1,265.00 253.00
Dan O'Connor 23.30 1,345.00 31,338.50
Carolin Paus 25.90 750.00 19,425.00
Yusuf Salloum 36.60 1,595.00 58,377.00
Anna Schwander 1.10 1,315.00 1,446.50
Scottie Shermetaro 17.50 1,575.00 27,562.50
Steve Toth 123.90 1,820.00 225,498.00
Donatus Wang 16.90 960.00 16,224.00
Nicholas Warther 1.00 1,665.00 1,665.00
Cristina Weidner 3.00 1,665.00 4,995.00
Spencer A. Winters, P.C. 5.90 1,685.00 9,941.50
Sara B. Zablotney, P.C. 0.30 2,445.00 733.50
Ali Mohammad Zarrabi 2.80 1,095.00 3,066.00
Ann-Kathrin Ziegler 3.20 1,070.00 3,424.00
TOTALS 411.30 $ 609,876.00
2
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 25 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108826
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Description of Legal Services
Date Name Hours Description
07/10/24 Cristina Weidner 2.00 Attend conferences re sale structuring.
10/01/24 Luke Finn 8.80 Participate in update telephone conferences
with S. Toth, Company re sale stream issues
(1.0); analyze issues re 503(b)(9) estimates
and 510k transfer matters (.6); review and
analyze correspondence re Swiss R&D and
share purchase agreement imtmedical ag
liabilities (2.2); review, analyze collected
signature pages (.5); correspond with Dutch,
Swiss and German co-counsels re sale issues
(1.3); review, analyze Brazilian credits
agreement and payment agreement (.4); draft
bills of sales for various ex-US entities (.8);
draft checklist re same (1.0); review, analyze
draft funds flow (.3); review Trench Rossi
correspondence re sale issues (.5); correspond
with Zoll re sale issues (.2).
10/01/24 Ruan J. Meintjes 0.70 Review and analyze patient health
information matters related to Zoll asset
purchase agreement amendment (.5); draft
summary of analysis re same (.1); coordinate
with A. Del Rio re same (.1).
10/01/24 Dan O'Connor 0.20 Correspond with L. Finn re escrow matters.
10/01/24 Carolin Paus 0.80 Revise asset purchase and transfer agreement.
10/01/24 Scottie Shermetaro 1.20 Review and revise APA amendment re
transferred IP.
10/01/24 Steve Toth 6.00 Analyze correspondence with L. Finn re Zoll
issues (.2); participate in all hands telephone
conference re Zoll issues (.5); analyze
correspondence re closing and tax issues (.8);
participate in exec steerco telephone
conference with Company, AlixPartners, L.
Finn, K&E team (.5); analyze correspondence
and update intercompany agreement (2.6);
analyze correspondence re Brazil matters (.7);
analyze correspondence re transfer
agreements and related closing items (.7).
3
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 26 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108826
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
10/01/24 Donatus Wang 1.90 Correspond with Company re notarization of
US PoAs and IP and inventory lists for MIM
and Vyaire GmbH (.6); correspond with
AlixPartners re asset lists for MIM and Vyaire
GmbH (.3); telephone conference with S.
Toth, K&E team re same (.2); review and
analyze schedules to ZOLL APA re
intellectual property, consider related
registration requirements (.4); coordinate
German notarization of MIM SPA (.2);
correspond with Cole Schotz re potential
German regulatory requirements (.2).
10/01/24 Nicholas Warther 0.70 Review and revise APA.
10/02/24 Hendrik Braun 1.00 Draft, revise PoAs and notarial statements for
German sale and transfer agreements.
10/02/24 Chris Ceresa 1.10 Correspond with Y. Salloum, Company,
advisors re open sale legal issues (.7); review
and analyze issues re same (.4).
10/02/24 Bernadette Coppola 0.20 Correspond with buyer, S. Toth, K&E team re
license agreement.
10/02/24 Anthony M. Del Rio 0.30 Review and comment on TSA and APA
amendment.
10/02/24 Luke Finn 4.60 Participate in telephone conferences with S.
Toth, K&E team re Zoll (1.0); prepare for
checklist call re same (.5); participate in
checklist telephone conference with various
parties re same (.5); analyze correspondence
re Swiss equity transfer with Baker McKenzie
Zurich and Van Doorne (.7); analyze, draft
first amendment to APA (.6); review, analyze
funds flow (.5); review, analyze
correspondence re bill of sales (.4); draft same
for various entities (.4).
10/02/24 Sabrina Lieberman 0.70 Telephone conference with H. Crawford,
Baker McKenzie, AlixPartners re Italian
entities with respect to sale (.5); correspond
with H. Crawford, K&E team re same (.2).
10/02/24 Maximilian Liegl 1.00 Review, analyze issues re corporate law
aspects of proposed asset and share sales.
10/02/24 Ruan J. Meintjes 0.40 Review and analyze transition services
agreement issues re PHI (.2); coordinate with
A. Del Rio re same (.2).
4
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 27 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108826
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
10/02/24 Carolin Paus 1.90 Review and analyze comments to APA (.7);
revise APA, TSA (.9); telephone conference
with S. Toth, K&E team re VAT clause in
APA (.3).
10/02/24 Yusuf Salloum 2.00 Analyze issues re sale closing.
10/02/24 Scottie Shermetaro 2.60 Review and revise first amendment to APA
(1.9); correspond with S. Toth, K&E team re
same (.7).
10/02/24 Steve Toth 14.30 Analyze correspondence re international
closing matters (.3); participate in all hands
telephone conference with various parties re
Zoll closing matters (1.2); analyze
intercompany agreement and closing checklist
(.3); revise intercompany agreement (.9);
revise notes re same (1.2); participate in
advisor update telephone conference with
Cole Schotz, L. Finn, K&E team and
AlixPartners (.7); discuss intercompany
transactions with N. Warther (.2); review,
revise intercompany agreement (1.7); review,
analyze issues re closing timing and business
(.3); discuss closing checklist with Cooley, L.
Finn, K&E team (.9); analyze correspondence
re intercompany issues and Brazil (.3);
review, analyze APA amendment (2.1);
review, revise same (2.2); review, revise
agency agreement (2.0).
10/02/24 Donatus Wang 1.00 Correspond with Company re equipment lists
for and contracts of MIM and Vyaire GmbH
for asset transfer agreement (.3); review
overview of accounts receivable of Vyaire
GmbH from AlixPartners (.2); correspond
with AlixPartners re same (.2); correspond
with German management counsel re status of
sale processes, Zoll closing (.3).
10/03/24 Bernadette Coppola 0.60 Conference with A. Del Rio, K&E team re
healthcare regulatory matters (.3); correspond
with Company, A. Del Rio, K&E team re
additional asset transfers and transition
services (.3).
10/03/24 Anthony M. Del Rio 0.80 Review and comment on TSA and APA open
items.
5
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 28 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108826
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
10/03/24 Luke Finn 7.10 Participate in telephone conference with S.
Toth, K&E team, various parties re sale
issues, updates (1.0); review,
analyze correspondence re Dutch APA,
international bill of sales, signature matrices,
Germany asset purchase and transfer
agreement (2.3); review, analyze Intermed
and other Brazilian matters with Trench Rossi
(.7); correspond with Company re
directorships, charters and signing authorities
and signature collection (1.8); review, analyze
K&N letter agreement matters (.4); review,
compile materials re Vyaire GmbH and MIM
IP assignments and Swiss equity transfers
(.9).
10/03/24 Kate Hardey 2.10 Telephone conference with A. Del Rio and R.
Meintjes re TSA PHI matters (.6); review and
analyze undisclosed agent agreement (.5);
comment on same (.5); draft correspondence
re same (.4); correspond with Company re
same (.1).
10/03/24 Ruan J. Meintjes 0.80 Review and analyze regulatory considerations
re Azure environment transfer (.5); coordinate
with A. Del Rio re same (.3).
10/03/24 Anna Schwander 0.60 Review, analyze issues re Italian FDI process.
10/03/24 Anna Schwander 0.20 Review, analyze correspondence re German
FDI process.
10/03/24 Scottie Shermetaro 0.20 Correspond with S. Toth, K&E team re
revisions to IP schedules.
6
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 29 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108826
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
10/03/24 Steve Toth 11.10 Analyze and revise agency agreement (3.8);
revise intercompany agreement (.2);
participate in all hands telephone conference
with L. Finn, K&E team re Zoll closing
matters (1.0); discuss issues with Company,
AlixPartners, PJT, L. Finn, K&E team (1.5);
review, analyze related correspondence (.2);
correspond re Italy matters with H. Crawford
(.5); correspond with Y. Salloum, K&E team
re same (.7); discuss funding matters with
AlixPartners and Y. Salloum (.3); participate
in telephone conference with Company, Y.
Salloum, K&E team, AlixPartners and PJT re
Zoll issues (.8); review, analyze
correspondence re same (.9); revise
intercompany agreement (.8); review, revise
agency agreement (.4).
10/03/24 Donatus Wang 0.50 Participate in update telephone conference
with German management counsel re sales
process (.2); correspond with Company on
notarization of PoAs for German share
transfers (.3).
10/03/24 Spencer A. Winters, P.C. 0.80 Review and analyze issues re Zoll closing.
10/03/24 Ann-Kathrin Ziegler 0.20 Telephone conference with German
management counsel re sales processes.
10/04/24 Chris Ceresa 0.30 Correspond with S. Toth, K&E team re sale
legal items.
10/04/24 Bernadette Coppola 0.30 Correspond with L. Finn, K&E team re bill of
sale (.1); correspond with A. Del Rio and
team re revisions to asset purchase agreement
amendment (.1); correspond with buyer, S.
Toth, K&E team re revisions to license
agreement (.1).
10/04/24 Anthony M. Del Rio 0.70 Review, analyze issues re TSA, APA (.3);
comment on same (.4).
7
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 30 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108826
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
10/04/24 Luke Finn 6.60 Participate in telephone conference with
various parties re sale updates (1.0); prepare
for check list call (.3); participate in checklist
telephone conference (.4); participate in
"Vyaire Sync" call (.7); coordinate with
AlixPartners, S. Toth, K&E team re Vyaire
GmbH and MIM GmbH matters (1.4);
review, analyze international bill of sales (.5);
telephone conference with Company re same
(.3); analyze AlixPartners correspondence re
inventory and AR schedules (1.6); review,
revise checklist (.4).
10/04/24 Ruan J. Meintjes 0.50 Review and analyze Zoll asset purchase
agreement amendment (.3); coordinate with
A. Del Rio re same (.2).
10/04/24 Trent Nachbar 0.20 Review, analyze bills of sale and assignments.
10/04/24 Yusuf Salloum 3.50 Review, analyze issues re closing sale
transaction.
10/04/24 Scottie Shermetaro 0.40 Review and revise IP disclosure schedules.
10/04/24 Steve Toth 3.40 Participate in all hands telephone conference
with L. Finn, K&E team re Zoll issues (1.0);
participate in exec steerco telephone
conference with Company and AlixPartners
(.3); analyze revised K&E agreement (.1);
analyze closing deliverables and related
correspondence (.6); participate in all hands
telephone conference with L. Finn, K&E team
re closing issues update (.8); discuss
intercompany issues with Company (.1); draft
correspondence re same (.1); correspond with
Company, L. Finn, K&E team and
AlixPartners re funding, related issues (.4).
10/04/24 Donatus Wang 6.10 Revise closing workstreams summary (.1);
correspond with Company re equipment,
inventory and contracts of MIM and Vyaire
GmbH (.3); prepare overview of assets to be
transferred to ZOLL (.8); correspond with S.
Toth, K&E team re same (.1); review, analyze
Zoll comments on draft asset transfer
agreement (.8); revise same (2.0); prepare
schedules on receivables, inventory and
equipment (1.5); correspond with S. Toth,
K&E team and AlixPartners re same (.5).
8
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 31 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108826
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
10/05/24 Bernadette Coppola 0.60 Telephone conference with B. Fernandez re
patent license (.4); correspond with Company,
S. Toth, K&E team re same (.2).
10/05/24 Hannah Crawford 0.20 Correspond with S. Toth re latest status re
sale transaction.
10/05/24 Luke Finn 2.40 Participate in Company call re sale updates
(.5); review, analyze respiratory knowledge
portal and patent transfers (.6); review,
analyze issues re VM Holdings BV
contingent payment (.1); review, analyze
correspondence with D. Wang, Van Doorne
re German and Dutch asset purchase
agreements (1.2).
10/05/24 Ruan J. Meintjes 0.30 Review and analyze Zoll asset purchase
agreement amendment.
10/05/24 Yusuf Salloum 1.00 Review, analyze issues re sale closing.
10/05/24 Scottie Shermetaro 0.80 Review and revise APA amendment.
10/05/24 Steve Toth 4.10 Analyze, revise APA amendment and update
attorney notes (1.2); participate in telephone
conference with Company, AlixPartners, S.
Winters and K&E team re Zoll closing
matters (1.2); review, analyze correspondence
re closing matters and APA issues (.7);
correspond with S. Winters, K&E team re
same (.7); participate in all hands telephone
conference with L. Finn, K&E team re Zoll
closing matters (.3).
10/05/24 Spencer A. Winters, P.C. 1.20 Participate in telephone conferences with
AlixPartners, Company, S. Toth, K&E team
re Zoll closing.
10/05/24 Sara B. Zablotney, P.C. 0.30 Review and comment on APA language.
10/06/24 Anthony M. Del Rio 0.30 Review, analyze issues re TSA and
amendment.
9
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 32 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108826
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
10/06/24 Luke Finn 6.80 Participate in all-hands telephone conference
re sales workstream (.3); review, analyze
issues re intercompany debt novations (.5);
review, analyze Vyaire GmbH asset purchase
agreement (.8); review, analyze
correspondence re same (.8); review, analyze
undisclosed agency agreement (.7); distribute
revised drafts of German and Dutch APAs to
Cooley (.4); review, analyze Cooley
comments to Vyaire B.V. asset purchase
agreement (.6); review, analyze
correspondence with Dutch counsel and
Company re intercompany liabilities (.3);
review, analyze nine bills of sale drafts
received from Cooley (.9); review, analyze
amendment to APA documents (.4) review,
analyze correspondence re same (.4); draft
Brazilian bill of sale documents (.6);
correspond with Trench Rossi re same (.1)
10/06/24 Sabrina Lieberman 0.30 Research precedent re APA amendments.
10/06/24 Carolin Paus 1.20 Review, analyze APA transfer agreement (.5);
draft comments re same (.4); revise
workstream summary (.3).
10/06/24 Yusuf Salloum 3.00 Analyze issues re sale closing.
10/06/24 Steve Toth 3.00 Discuss sale closing issues with Company,
AlixPartners, Y. Salloum and K&E team
(1.0); review, analyze correspondence re same
(.3); correspond with Y. Salloum, K&E team
re creditor updates (.7); review, analyze APA
amendment (.6); review, analyze
correspondence re IP and APA matters (.4).
10/06/24 Donatus Wang 1.00 Review, analyze ZOLL comments on asset
purchase and transfer agreement (.7); revise
same (.3).
10/06/24 Spencer A. Winters, P.C. 0.30 Review and analyze Zoll closing issues.
10/07/24 Bernadette Coppola 0.40 Correspond with Company re patent license
(.2); correspond with buyer's counsel re same
(.1); correspond with S. Toth and K&E team
re amendment to asset purchase agreement
(.1).
10
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 33 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108826
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
10/07/24 Luke Finn 9.30 Review Cooley draft of agency agreement
(.4); review, analyze correspondence re
Brazilian entity tax and restructuring (.4);
review, analyze correspondence with
Singapore co-counsel (.2); review, analyze
sale documents re German entities (.8);
correspond with Swiss co-counsel re closing
logistics (.4); review, revise CPAP patent
issues (.3); review, analyze Chinese
enforceability issues (.5); review, analyze
letter agreement (.6); draft German entity
asset purchase agreement documents (.8);
distribute German entity asset purchase
agreement documents (.2); coordinate,
manage checklist call (.4); review and revise
asset purchase agreements for Vyaire Medical
Holdings BV and Vyaire BV entities (1.1);
compile TSA schedules (.9); correspond with
Company, various parties re sale closing
issues (1.3); participate in telephone
conference with various parties re same (1.0).
10/07/24 Carolin Paus 3.90 Review, analyze comments to APAs (1.0);
correspond with C. Weidner, K&E team re
same (.7); analyze, review Zoll APA re
allocation and limitation of liability (1.3);
draft execution version of the asset purchase
and transfer agreement (.4); correspond with
German notary re KYC documents
requirements (.5).
10/07/24 Scottie Shermetaro 0.50 Draft patent schedule for acquired assets.
11
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 34 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108826
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
10/07/24 Steve Toth 9.90 Analyze correspondence re closing and
international updates (.2); participate in all
hands telephone conference with various
parties re Zoll closing (.8); telephone
conference with AlixPartners, Y. Salloum,
K&E team re sale updates (1.1); participate in
exec steerco telephone conference with
Company, AlixPartners, Y. Salloum, K&E
team (.5); review, analyze amendment to
APA (.8); correspond with Company, PJT, L.
Finn, K&E team and AlixPartners re business
updates (.4); review, revise APA amendment
(.6); participate in special committee
telephone conference with Company, PJT,
Alix, S. Winters, K&E team (.4); analyze and
revise agency agreement (1.6); correspond
with UCC advisors, AlixPartners, Y. Salloum,
K&E team and Cole Schotz re business
updates (.8); review, revise APA amendment
and agency agreement (.3); correspond with
Zoll, Cooley, AlixPartners, Company, Y.
Salloum, K&E team re same (.9); revise
agency agreement (.4); review, analyze Brazil
agreements (.2); review, analyze
correspondence re foreign agreements (.9).
10/07/24 Donatus Wang 1.00 Prepare execution versions of asset sale
approval shareholder resolutions (.4); instruct
C. Paus on preparation of execution version
of Asset Purchase and Transfer Agreement
(.2); correspond with Company and German
notary on notary KYC requests (.4).
10/07/24 Spencer A. Winters, P.C. 1.30 Review and analyze issues re Zoll closing
(.8); prepare for special committee meeting
(.2); participate in same (.3).
10/08/24 Bernadette Coppola 0.30 Correspond with buyer's counsel,
AlixPartners, S. Toth, K&E team re transition
services agreement schedules (.2); correspond
with buyer's counsel, S. Toth and K&E team
re amendment to asset purchase agreement
(.1).
12
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 35 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108826
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
10/08/24 Michael Ehret 1.70 Correspond with D. Wang re asset transfer
agreement for MIM IP (.3); correspond with
Company re same (.2); analyze draft overview
re same (.7); correspond with L. Finn, K&E
team re transfer agreement re IP (.5).
10/08/24 Luke Finn 8.10 Participate in all hands telephone conference
re Zoll closing (.8); prepare for same (.2);
prepare checklist re foreign entities call (.6);
participate in same (.4); telephone conference
with S. Toth, K&E team, Company re Italy
and Brazil entities (.5); review, analyze MIM
assets and liabilities (.3) review, analyze
correspondence re Chinese entity (.4); review,
analyze correspondence re Brazilian entity
(.6); revise German IP assignment draft (.4);
prepare schedules of inventory and AR (.8);
review, analyze updated agency agreement
draft (.4); revise signature matrix summary
(.8); research RKP patent (1.2); review,
analyze intercompany settlement agreement
(.7).
10/08/24 Dan O'Connor 1.30 Correspond with Company re IP matters (.3);
correspond with L. Finn re closing matters
(.2); telephone conference with S. Toth, K&E
team, Company, Zoll re Zoll closing (.8).
10/08/24 Yusuf Salloum 3.20 Analyze issues re closing sale transaction.
13
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 36 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108826
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
10/08/24 Steve Toth 10.50 Participate in telephone conference with L.
Finn, K&E team, Company, Zoll re Zoll
closing (.8);analyze correspondence re same
(.3); participate in exec steerco telephone
conference with Company and AlixPartners
(.4); telephone conference with Cole Schotz
and AlixPartners re sale process updates (.9);
analyze correspondence re intercompany
issues (.1); telephone conference with
Company, AlixPartners, L. Finn, K&E team
re Brazil and Italy matters (.5); review,
analyze issues re same (.3); review, analyze
agency agreement (.3); analyze Brazil
transaction documents (2.1); correspond with
L. Finn, K&E team and Cooley re checklist
(.2); correspond with Company re
intercompany issues (.5); review, revise
intercompany and Brazil documents (1.3);
review, analyze APA amendment (.2);
correspond with AlixPartners and Company
re A/R and funds flow (.7); review, analyze
Brazil sale agreement (.3); telephone
conference with Company re inventory in
transit issues (1.0); review, analyze issues re
same (.3); correspond with Y. Salloum re sale
(.3).
10/08/24 Donatus Wang 1.00 Analyze issues re German legal aspects re
asset purchase and transfer agreement (.6);
telephone conference with C. Paus re same
(.4).
10/09/24 Bernadette Coppola 2.40 Review, analyze issues re patents (.5);
conference with L. Finn re same (1.4); draft
revisions to amendment to asset purchase
agreement (.3); correspond with S. Toth and
K&E team re same (.2).
14
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 37 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108826
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
10/09/24 Luke Finn 11.30 Telephone conference with Company, S.
Toth, K&E team re Zoll closing (.8); prepare
for same (.2); telephone conference with S.
Toth, K&E team re same (.5); telephone
conference with UCC advisors, Zoll, S. Toth,
K&E team re same (.7); prepare for same (.6);
review, analyze Zoll drafts of German and
Dutch purchase agreements (1.1); review and
revise Swiss checklist (.3); coordinate signing
processes in Switzerland (.4); review, analyze
correspondence re MIM IP assignment
agreement matters (.5); review, analyze
Chinese VAT and consideration payment
matters (.6); research RKP license (.5);
telephone conference with B. Coppola re
same (1.4); review, analyze issues re Chinese
distribution agreement planning (.4); revise
intercompany settlement agreement (.8);
review, analyze Vyaire BV’s AR and
Inventory schedules (.5); review, analyze
Non-U.S. non-tax assumed payables requests
(.3); revise attachment to schedule 3.11(A)
(.7); revise international bills of sale drafts
(.6); correspond with Feijo re same (.4).
10/09/24 Luke Finn 2.20 Review, analyze updated funds flow from
AlixPartners (.3); review, analyze Brazil and
Intermed restructuring plans (.1); revise
Brazilian bills of sales (.2); revise schedules
re intercompany settlement agreement (.5);
correspond with Company re officers
certificate, bringdown communications (.4);
correspond with various international parties
re sale closing plans (.4); correspond with
Company re updated APAs (.3).
10/09/24 Carolin Paus 3.30 Correspond with C. Weidner re German asset
purchase and transfer agreement (1.2); review
and analyze counterparty comments re
German asset purchase and transfer
agreement (.9); revise German asset purchase
and transfer agreement (1.2).
10/09/24 Yusuf Salloum 3.80 Analyze issues re closing sale transaction.
10/09/24 Steve Toth 1.30 Analyze correspondence re APA amendment,
tax matters and intercompany agreement.
15
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 38 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108826
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
10/09/24 Steve Toth 8.40 Participate in telephone conference with
various parties re Zoll closing (.8); analyze
correspondence re same (.2); correspond with
AlixPartners, Company, Y. Salloum, K&E
team re sale closing status, next steps (.2);
telephone conference with L. Finn, K&E
team, AlixPartners, Zoll and UCC advisors re
sale closing updates (.7); analyze
intercompany agreement and related
correspondence (.6); analyze correspondence
re Brazil, Italy and China entities (.5); analyze
correspondence re closing and diligence (.3);
review, analyze correspondence re APA
amendment (.4); review, analyze agency
agreements and related correspondence (1.3);
correspond with L. Finn re closing checklist
(.7); review, analyze correspondence re same
(.2); participate in all hands telephone
conference re Zoll closing (1.4); draft
language for TSA schedule (.3); revise non-
US agency agreement (.3); revise US agency
agreement (.4); analyze correspondence re
stipulation (.1).
10/09/24 Donatus Wang 2.10 Review, analyze comments on draft asset
purchase and transfer agreement (.5); revise
same (1.0); analyze, coordinate notarization
of PoAs to German SPAs and secretary
certificates (.6).
10/09/24 Cristina Weidner 1.00 Correspond with D. Wang, K&E team re
APA comments.
10/09/24 Spencer A. Winters, P.C. 0.50 Review, analyze issues re committee motion
re sale and closing status.
10/10/24 Hendrik Braun 0.50 Correspond with S. Toth, K&E team re
German APA issues.
10/10/24 Bernadette Coppola 0.40 Correspond with L. Finn and K&E team re
intellectual property schedules (.2);
conference with S. Toth and S. Shermetaro re
same (.2).
10/10/24 Luke Finn 1.80 Review, analyze schedule 3.11 (.4);
coordinate Company signatures (.8); review,
revise Chinese distribution agreement (.2);
compile Swiss documents (.4).
16
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 39 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108826
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
10/10/24 Luke Finn 11.90 Telephone conference with S. Toth, K&E
team, AlixPartners, Company, Zoll re Zoll
sale closing (.8); prepare for same (.2);
telephone conference with Cooley re Zoll
checklist (.6); prepare for same (.4);
participate in telephone conferences with
various parties closing requirements (1.6);
review, analyze Swiss contribution
agreements (.4); correspond with Company re
Swiss directors logistics, issues (.3); draft
escrow release letters (.5); review
intercompany settlement schedule updates
(.5); review, analyze updated funds flow and
Vyaire BV AR schedule (.5); review, analyze
agreement executions and other closing
packet preparation matters with Company and
opposing counsel (2.1); analyze
correspondence with Brazilian consultant (.3);
draft, finalize international bills of sale (.8);
draft, finalize international asset purchase
agreements and schedules (1.4); finalize
arrangements for Zurich in person signing
(.5); review, analyze purchaser's signatures
(.6); revise IP schedules to APA amendment
(.4).
10/10/24 Justin M. Garfinkle 0.30 Review, analyze Zoll IP schedules.
10/10/24 Palmer Gunderson 1.00 Telephone conference with N. Warther, K&E
team re settlement agreement (.4); draft
revised language for settlement agreement
(.3); correspond with S. Toth, K&E team re
settlement agreement and sale closing
considerations (.3).
10/10/24 Dan O'Connor 1.30 Prepare escrow release letter (.3); correspond
with Company re escrow release letter (.2);
telephone conferences with Zoll, Company,
L. Finn, K&E team re Zoll closing (.8).
10/10/24 Carolin Paus 0.50 Review and analyze Zoll comments re
German asset purchase and transfer
agreement.
10/10/24 Yusuf Salloum 4.50 Review, analyze issues re closing of sale
transactions.
10/10/24 Scottie Shermetaro 1.50 Review and revise APA amendment and
schedules re assigned IP.
17
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 40 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108826
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
10/10/24 Steve Toth 3.20 Telephone conference with Cooley re
503(b)(9) considerations (.4); correspond with
Cooley re same (.3); analyze correspondence
re closing matters (1.4); correspond with Zoll,
Company, L. Finn, K&E team re same (.8);
telephone conference with L. Finn re
signature releases (.3).
10/10/24 Steve Toth 5.40 Analyze correspondence re international
updates (.4); telephone conference with
Company, Zoll, L. Finn, K&E team re Zoll
closing (.6); review, analyze international
documents and intercompany agreement (.8);
participate in exec steerco telephone
conference with Company and AlixPartners
(.3); review, analyze APA amendment (.2);
telephone conference with Cole Schotz, Alix
Partners, L. Finn, K&E team re same (.2);
review, analyze closing checklist (.3);
telephone conference with Zoll, L. Finn, K&E
team, Company re Zoll closing (.4);
participate in special committee telephone
conference with Company, AlixPartners, PJT,
Y. Salloum, K&E team (.2); telephone
conference with Zoll, Cooley, AlixPartners,
Company re funds flow (.9); review, analyze
correspondence re intercompany agreement
(.3); correspond with Company re funds flow
issues (.1); correspond with Cooley, L. Finn,
K&E team re closing checklist (.4); review,
analyze correspondence re closing matters
(.3).
10/10/24 Steve Toth 4.00 Participate in telephone conference with
Company and AlixPartners re Brazil matters
(.2); participate in all hands telephone
conference re Zoll closing (.4); revise Brazil
sale document (.3); revise IP schedules (.3);
review, analyze correspondence re closing
matters (2.8).
10/10/24 Donatus Wang 0.20 Correspond with S. Toth, K&E team re asset
purchase and transfer agreement.
10/11/24 Michael Ehret 0.40 Correspond with Company re closing vents.
18
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 41 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108826
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
10/11/24 Luke Finn 6.50 Review, analyze, coordinate signature
collection (.3); review, coordinate Zurich
signing with Swiss co-counsel (.9); review,
analyze issues re closing process,
communications logistics (1.2); review,
analyze issues re grandfather receivables (.4);
review, analyze, distribute wire instructions
(.3); review, analyze, compile final
documentation re same (.7); review, analyze
immediate post-closing matters (1.6); review,
analyze issues re escrow release matters (.4);
review, analyze Vyaire Medical Holdings BV
authorization issues with opposing counsel
(.2); correspond with Company re post-
closing matters (.5).
10/11/24 Carolin Paus 1.70 Review, revise workstream summary re Zoll
closing (.7); correspond with S. Toth, K&E
team re post-closing workstream issues (.2);
correspond with S. Toth, K&E team re
Trudell closing requirements, documents (.6);
correspond with Company re executed
shareholder resolutions (.2).
10/11/24 Yusuf Salloum 1.00 Analyze issues re closing of sale transaction.
10/11/24 Steve Toth 6.00 Analyze issues re Swiss matters, sale closing
(3.9); analyze correspondence re same (.8);
correspond with Y. Salloum, K&E team re
same (1.1); correspond with Cole Schotz,
AlixPartners, Y. Salloum, K&E team re
corporate matters (.2).
10/11/24 Donatus Wang 0.50 Correspond with Company re closing of
transaction and post-closing matters.
10/12/24 Luke Finn 0.60 Correspond with Singapore, Chinese and
Brazilian counsel (.4); correspond with
opposing counsel re filing (.2).
10/14/24 Luke Finn 1.90 Prepare for telephone conference re RDx (.3);
telephone conference with Company, S. Toth,
K&E team re same (.4); correspond with
Company re post-closing matters re Zoll (.3);
correspond with international local counsels
re post-closing matters re Zoll deal (.4);
correspond with opposing counsel re closing
volume and exchange procedures (.5).
19
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 42 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108826
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
10/14/24 Dan O'Connor 2.50 Telephone conference with L. Finn re foreign
subsidiary transfers (.4); correspond with L.
Finn re same (.1); review and revise closing
checklist (.5); draft foreign subsidiary transfer
checklist (1.0); correspond with J. Mudhar,
K&E team re ex-US asset and equity transfer
process (.3); correspond with Company re
FDI filings (.2).
10/14/24 Steve Toth 1.80 Participate in executive steerco telephone
conference with Company and AlixPartners
(.4); participate in advisor update telephone
conference with Cole Schotz, AlixPartners, Y.
Salloum, K&E team (.5); analyze
correspondence re closing matters (.9).
10/14/24 Donatus Wang 0.20 Review, analyze apostilled PoA for Breathe
US and secretary certificate for PoA for VMI.
10/15/24 Luke Finn 2.20 Correspond with Company re Brazil sales and
intercompany agreement (.4); draft and
distribute escrow release letter (.5); review
and distribute Swiss agreement (.3); analyze,
coordinate closing set preparation with
opposing counsel (.7); analyze issues re
closing set with Company (.3).
10/15/24 Dan O'Connor 1.10 Correspond with KWM team re Australian
subsidiary equity transfer matters (.4);
correspond with LeeKo team re South Korean
subsidiary equity transfer matters (.4);
correspond with AlixPartners and Company
re closing matters (.3).
10/15/24 Carolin Paus 0.80 Draft correspondence to D. Wang and
Company re required documents re Trudell
closing, VMI registration (.5); revise
workstream summary (.3).
10/15/24 Yusuf Salloum 1.00 Analyze issues re sale transaction.
10/15/24 Steve Toth 1.90 Participate in advisor update telephone
conference with PJT, AlixPartners, Y.
Salloum, K&E team (.1); participate in
telephone conference re tax insurance with
Company, PJT, AlixPartners, Y. Salloum,
K&E team (.4); correspond with Company re
same (.2); analyze correspondence re closing
matters (.3); analyze APA (.9).
10/15/24 Donatus Wang 0.10 Correspond with C. Paus re Trudell closing.
20
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 43 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108826
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
10/15/24 Spencer A. Winters, P.C. 1.10 Review and analyze issues re RDx closing
(.6); telephone conference with Company, S.
Toth, K&E team re same (.4); prepare for
same (.1).
10/16/24 Luke Finn 2.60 Analyze, coordinate escrow release,
distribution (.4); analyze issues re German
and Italian entities (.2); correspond with
Company re closing volume (.4); analyze
compiled closing volume documents (.7);
review, analyze correspondence re
intercompany settlement agree schedules (.5);
analyze, distribute executed intercompany
documents (.3); coordinate RDx closing
logistics call (.1).
10/16/24 Dan O'Connor 0.40 Correspond with Company re intercompany
settlement matters.
10/16/24 Carolin Paus 0.70 Telephone conference with M. Ehret re
purchase price of MIM, corresponding tax
implications.
10/16/24 Carolin Paus 1.20 Review, analyze KYC documents (.6);
correspond and coordinate with German
notary re same (.2); correspond with S. Toth,
K&E team re Vyaire Medical GmbH (.4).
10/16/24 Yusuf Salloum 2.00 Analyze issues re sale closing.
10/16/24 Steve Toth 5.30 Analyze APA (.4); draft comments re same
(.2); correspond with Company, AlixPartners
re same (.9); draft further comments re same
(3.4); analyze correspondence re same (.3);
correspond with Company re next steps re
same (.1).
10/16/24 Donatus Wang 1.10 Telephone conference with S. Toth, K&E
team re novation (1.0); analyze notarized and
apostilled officer's certificate for PoA of
Breathe US for sale of Vyaire Medical GmbH
(.1).
10/16/24 Ann-Kathrin Ziegler 1.00 Telephone conference with M. Ehret, K&E
team re sale mechanics for VM GmbH (.8);
prepare for same (.2).
10/17/24 Hendrik Braun 1.50 Review, analyze German share purchase and
transfer agreements.
21
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 44 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108826
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
10/17/24 Michael Ehret 1.40 Correspond with Company re fair market
value determination, MIM disposal, Trudell
transaction (.4); telephone conference with S.
Winters, K&E team, Company re same (1.0).
10/17/24 Luke Finn 1.10 Analyze sale updates (.3); telephone
conference with AlixPartners, D. O’Connor,
K&E team, Company re RDx closing
logistics (.5); prepare for same (.1); analyze
escrow issues (.2).
10/17/24 Dan O'Connor 1.00 Telephone conference with AlixPartners and
Company re closing matters (.5); review and
revise closing checklist (.5).
10/17/24 Yusuf Salloum 2.00 Analyze issues re sale closing, insurance.
10/17/24 Steve Toth 1.80 Correspond re insurance structure (.6);
correspond re TSA matters with AlixPartners,
Y. Salloum, K&E team (.3); prepare related
correspondence (.1); correspond with
Company re APA (.8).
10/17/24 Donatus Wang 0.20 Correspond with Trudell counsel re sale.
10/18/24 Michael Ehret 0.20 Analyze draft SPA, transfer agreement.
10/18/24 Luke Finn 1.20 Correspond with closing counsel re closing
volume matters and intercompany settlement
documents (.8); analyze counsel
correspondence re Brazil wire payment (.2);
analyze counsel correspondence re Swiss
document handover (.2).
10/18/24 Dan O'Connor 0.50 Correspond with Company, S. Toth and Y.
Salloum re engagement of Italy counsel.
10/18/24 Yusuf Salloum 1.50 Analyze issues re sale transaction.
10/18/24 Steve Toth 1.80 Correspond with UCC advisors, AlixPartners,
Cole Schotz, Y. Salloum, K&E team re
transaction updates (.8); correspond with PJT,
Company, Y. Salloum, K&E team re sale
insurance update (1.0).
10/19/24 Luke Finn 1.00 Review, analyze draft of closing volume.
10/19/24 Dan O'Connor 0.40 Telephone conference with Company, M. Y.
Salloum, K&E team re sale tax matters.
10/19/24 Steve Toth 0.40 Correspond with PJT, Company, Y. Salloum,
K&E team re sale insurance update.
10/19/24 Spencer A. Winters, P.C. 0.40 Telephone conference with Company and
advisors re Trudell status update (.3); prepare
for same (.1).
22
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 45 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108826
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
10/21/24 Bernadette Coppola 0.10 Correspond with Company, S. Toth, K&E
team re revisions to purchase agreement.
10/21/24 Luke Finn 2.00 Analyze correspondence with Swiss co-
counsel re close-out and handover (.4); draft
memorandum for Company re VMI
agreement, import and export requirements
(.7); correspond with Cooley re closing
volume matters and intercompany settlement
schedules (.5); analyze final closing volume
(.4).
10/21/24 Justin M. Garfinkle 1.80 Draft comments to Blender purchase
agreement.
10/21/24 Kate Hardey 1.50 Review and revise Blender product purchase
agreement (1.0); conference with R. Meintjes
re same (.5).
10/21/24 Ruan J. Meintjes 1.00 Review and revise Perma Pure asset purchase
agreement (.9); coordinate with K. Hardey re
the same (.1).
10/21/24 Carolin Paus 4.50 Review and analyze feedback from H. Braun
on share purchase agreement and share
transfer agreement (1.4); revise same (1.0);
telephone conference with H. Braun and A.
Ziegler re agenda for call with ASD (.5);
telephone conference with ASD re transfer of
Vyaire Medical GmbH (.5); correspond with
H. Braun, K&E team re draft transfer
agreement (.4); correspond with D. O'Connor,
K&E team re draft share transfer agreement
(.7).
10/21/24 Yusuf Salloum 1.50 Analyze issues re sale transactions closing.
10/21/24 Anna Schwander 0.30 Correspond with H. Braun, K&E team re FDI
Germany clearance.
10/21/24 Steve Toth 0.40 Analyze tax closing matters (.1); correspond
with Y. Salloum, K&E team re same (.3).
10/21/24 Ann-Kathrin Ziegler 1.00 Telephone conference with ASD re German
share transfer agreement (.2); telephone
conference with C. Paus and H. Braun re
same (.1); prepare for same (.2); review and
revise draft correspondence from C. Paus re
follow up to K&E team re Trudell sale
German law transfer (.5).
23
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 46 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108826
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
10/22/24 Luke Finn 1.40 Analyze issues re Italian entity structure and
tender notifications (.5); analyze co-counsel
contact details for RDx deal (.4); correspond
with Company re Intercompany settlement
agreement and step plan (.5).
10/22/24 Justin M. Garfinkle 0.40 Analyze issues re Blender purchase
agreement.
10/22/24 Kate Hardey 1.20 Review and revise Blender product purchase
agreement.
10/22/24 Carolin Paus 0.70 Correspond with A. Prestel re share transfer
agreement (.3); analyze APA re costs
provision, German notary fees (.4).
10/22/24 Yusuf Salloum 1.60 Analyze issues re sale closing.
10/22/24 Scottie Shermetaro 2.30 Review and revise Blender purchase
agreement.
10/22/24 Steve Toth 4.50 Analyze correspondence with Company and
AlixPartners re TSAs and closing (.4);
correspond with Company and AlixPartners
re cars and insurance for sale (.5); correspond
re tax insurance and related sale matters with
Y. Salloum, K&E team and Company (.5);
correspond re sale insurance update with Y.
Salloum (.3); correspond re TSA matters with
Y. Salloum and AlixPartners (.8); participate
in advisor update telephone conference with
Y. Salloum, K&E team, Cole Schotz and
AlixPartners (.4); analyze issues list re APA
(.4); analyze blenders APA (1.2).
10/23/24 Luke Finn 0.70 Analyze, revise schedule of conveyed IP
assets (.3); correspond with Swiss and Dutch
counsel re document hand over (.2); review,
analyze Brazil wire payments correspondence
(.2).
10/23/24 Dan O'Connor 2.40 Review and revise closing checklist (.6);
telephone conference with Company re same
(.5); review and revise Italy, Australia and
Germany equity transfer documents (1.3).
10/23/24 Carolin Paus 2.30 Review and analyze comments re draft SPA
re MIM (.5); revise SPA to reflect feedback
(.4); revise workstream summary (.3); review
and analyze correspondence re tax insurance
(.6); telephone conference with M. Ehret and
H. Braun re tax insurance (.5).
24
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 47 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108826
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
10/23/24 Yusuf Salloum 1.50 Prepare for sale closing.
10/23/24 Steve Toth 4.80 Correspond with Company re transaction
issues list (1.0); correspond with Y. Salloum
and K&E team re tax insurance sale matters
(.4); analyze closing matters (.3); participate
in advisors update telephone conference with
Y. Salloum, K&E team, Cole Schotz and
AlixPartners (.9); correspond with Company
and counterparty advisors re issues list (1.6);
revise GmbH resolutions draft (.6).
10/23/24 Nicholas Warther 0.30 Correspond with P. Gunderson, K&E team re
documents for wind-down.
10/23/24 Ann-Kathrin Ziegler 1.00 Telephone conference with C. Weidner, K&E
team re RDX sale insurance and request for
shareholder resolution (.8); prepare for same
(.2).
10/24/24 Bernadette Coppola 0.10 Correspond with S. Shermetaro re purchase
agreement.
10/24/24 Luke Finn 0.70 Analyze, revise disclosure schedule 1.2(p)
(.2); correspond with Swiss co-counsel re
document hand over (.2); distribute final
documents to co-counsels (.3).
10/24/24 Justin M. Garfinkle 1.70 Analyze IP schedules (.2); draft updates to
Blender purchase agreement (1.5).
10/24/24 Dan O'Connor 1.20 Draft summary of ex-US equity transfers
(1.0); correspond with Company re same (.2).
10/24/24 Carolin Paus 0.70 Review and revise shareholders resolution for
VMG.
10/24/24 Carolin Paus 0.50 Correspond with D. O'Connor re required
documents for share transfer (.3); correspond
with Company re required apostilled PoAs
(.2).
10/24/24 Yusuf Salloum 1.40 Prepare for sale closing.
10/24/24 Scottie Shermetaro 1.50 Review and revise asset purchase agreement.
10/24/24 Steve Toth 0.90 Correspond with Company, Y. Salloum and
K&E team re tax update (.1); participate in
advisor update telephone conference with Y.
Salloum and K&E team, Cole Schotz and
AlixPartners (.5); analyze correspondence
from AlixPartners, Company re APAs and
closings (.3).
25
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 48 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108826
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
10/25/24 Luke Finn 1.20 Analyze correspondence from Brazilian
counsel re Brazilian IP issues (.4); analyze
correspondence from Brazilian counsel re
wire payment (.2); analyze transitional
services agreement (.2); review, analyze
correspondence from Chinese counsel re
Chinese sales (.1); analyze correspondence
with Company and Cooley re Vents ICO
Settlements (.3).
10/25/24 Yusuf Salloum 0.70 Analyze issues re sale closing.
10/25/24 Steve Toth 0.40 Correspond with D. O’Connor, K&E team,
Company re closing and tax structure matters.
10/26/24 Bernadette Coppola 0.20 Draft revisions to asset purchase agreement.
10/26/24 Justin M. Garfinkle 0.50 Analyze Blender asset purchase agreement.
10/26/24 Scottie Shermetaro 1.00 Review and revise Blender purchase
agreement.
10/27/24 Justin M. Garfinkle 0.40 Review, revise Blender purchase agreement.
10/27/24 Scottie Shermetaro 0.20 Review and revise Blender asset purchase
agreement.
10/28/24 Chris Ceresa 0.40 Correspond with Y. Salloum, K&E team and
counsel re open sale issues.
10/28/24 Bernadette Coppola 0.20 Correspond with S. Shermetaro and K&E
team re revisions to asset purchase agreement.
10/28/24 Michael Ehret 0.80 Telephone conference with Company, Y.
Salloum, K&E team re draft memorandum,
intra-group share transfers re MIM, Trudell.
10/28/24 Luke Finn 0.40 Analyze sale issues (.2); review, analyze sale
with Van Doorne (.1); correspond with N.
Warther re sale (.1).
10/28/24 Justin M. Garfinkle 1.40 Analyze issues re Blender purchase
agreement.
10/28/24 Palmer Gunderson 0.20 Correspond with M. Ehret re sale planning.
10/28/24 Dan O'Connor 2.10 Correspond with Company re sale of Vyaire
Medical srl (1.0); correspond with Company
re U.S. offer letters (.3); prepare ancillary
transaction documents (.8).
10/28/24 Scottie Shermetaro 0.60 Review and revise Blender sale APA.
26
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 49 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108826
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
10/29/24 Bernadette Coppola 1.90 Conference with S. Toth, K&E team,
Company, and buyer re purchase agreement
(.6); draft revisions to purchase agreement
(1.1); correspond with S. Shermetaro and J.
Garfinkle re revisions to purchase agreement
(.2).
10/29/24 Luke Finn 0.30 Correspond with J. Garfinkle re Blender IP
purchase agreement (.1); analyze ZOLL
purchase agreement details(.2).
10/29/24 Justin M. Garfinkle 0.80 Analyze issues re Blender purchase
agreement.
10/29/24 Kate Hardey 1.00 Attend telephone conference with Company
and opposing counsel re Blender purchase
agreement.
10/29/24 Ruan J. Meintjes 0.80 Review and revise purchase agreement (.5);
telephone conference with K. Hardey, K&E
team re same (.3).
10/29/24 Dan O'Connor 1.00 Telephone conference with AlixPartners,
Company re non-debtor transaction matters
(.5); correspond with Company re FDI
notification and quota transfer deed matters
(.5).
10/29/24 Scottie Shermetaro 2.70 Participate in Blender telephone conference
with S. Toth, K&E team, Company and
potential buyer (1.0); review and revise Perma
Pure APA (1.7).
10/29/24 Steve Toth 2.40 Analyze Blender APA (.3); participate in
telephone conference with Y. Salloum, K&E
team and Company re tax updates (.4);
participate in advisor update telephone
conference with Y. Salloum, K&E team,
AlixPartners and Cole Schotz (.5); correspond
with bidder, Company, K. Hardey, K&E team
re Blender APA (.5); correspond with
Company, AlixPartners, D. O’Connor, K&E
team re non-debtor sale updates (.5); analyze
correspondence re payroll, intercompany
balances (.1); correspond with Company re
same (.1).
10/30/24 Luke Finn 0.70 Analyze correspondence with D. O'Connor re
subsidiary corporate governance (.5);
analyze correspondence re final sale
documents (.2).
27
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 50 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108826
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
10/30/24 Sabrina Lieberman 0.60 Conference with buyer, buyer advisors,
Company, S. Toth, K&E team re transaction
closing.
10/30/24 Ruan J. Meintjes 0.70 Review and revise asset purchase agreement.
10/30/24 Dan O'Connor 4.00 Telephone conference with Trudell, Vyaire,
Deloitte, AlixPartners, S. Toth and K&E
teams re transaction matters (.5); correspond
with AlixPartners re TSA matters (.3);
telephone conference with Company re
foreign corporate governance matters (1.0);
prepare closing punch list re same (.8);
correspond with Company re closing matters
(.5); correspond with Company re transaction
matters (.5); review and revise closing
checklist (.4).
10/30/24 Steve Toth 2.80 Participate in all hands telephone conference
with D. O’Connor, K&E team re Trudell
closing preparation (.5); participate in advisor
telephone conference with Y. Salloum and
K&E team, Cole Schotz and AlixPartners
(.6); analyze Blender APA (1.6); correspond
with B. Coppola re closing matters (.1).
10/30/24 Ali Mohammad Zarrabi 2.80 Review, analyze VDR and other sale related
documents (1.0); prepare APA amendment,
officer certificates (1.1); analyze
correspondence re same (.7).
10/31/24 Bernadette Coppola 0.20 Correspond with S. Toth and K&E team re
termination of transition services agreement
services (.1); correspond with S. Shermetaro
and K&E team re purchase agreement
analysis (.1).
10/31/24 Luke Finn 0.40 Analyze filing matters for closing volume
with L. Jenkins.
10/31/24 Justin M. Garfinkle 0.70 Research assignability of Company lists.
10/31/24 Kate Hardey 1.60 Review and revise purchase agreement
regulatory provisions.
10/31/24 Dan O'Connor 3.90 Review and revise closing checklist (1.0);
review and revise closing punch list (.5);
review, analyze funds flow (.6); correspond
with Company re equity transfer matters (.3);
review and revise equity transfer agreements
(1.1); prepare related resolutions for Italy and
Australia (.4).
28
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 51 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108826
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
10/31/24 Carolin Paus 1.20 Review and analyze comments re sale of
MIM (.3); revise same (.2); conference with
C. Weidner and M. Ehret re maturity date of
purchase price claim and potential set-off (.4);
revise draft re same (.3).
10/31/24 Yusuf Salloum 1.40 Analyze issues re sale closing.
10/31/24 Scottie Shermetaro 2.00 Review and revise Perma Pure APA (1.1);
conduct diligence re sale of customer lists for
legacy products (.9).
10/31/24 Steve Toth 4.10 Telephone conference with Y. Salloum, K&E
team re sale updates (.9); participate in
advisor telephone conference with Y Salloum
and K&E team, AlixPartners and Cole Schotz
(.6); telephone conference with D. O’Connor
re Trudell issues (.2); correspond with Cole
Schotz re Blender APA bankruptcy issues
(.3); revise Blender APA (2.1).
10/31/24 Spencer A. Winters, P.C. 0.30 Review and analyze issues re sale closing and
settlement.
Total 411.30
29
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 52 of 95
601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
December 6, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050108827
Client Matter: 48520-11
In the Matter of Executory Contracts & Unexpired Leases
For legal services rendered through October 31, 2024
(see attached Description of Legal Services for detail) $ 635.50
Total legal services rendered $ 635.50
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 53 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108827
Vyaire Medical Inc. Matter Number: 48520-11
Executory Contracts & Unexpired Leases
Summary of Hours Billed
Name Hours Rate Amount
Sabrina Lieberman 0.10 975.00 97.50
Dan O'Connor 0.40 1,345.00 538.00
TOTALS 0.50 $ 635.50
2
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 54 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108827
Vyaire Medical Inc. Matter Number: 48520-11
Executory Contracts & Unexpired Leases
Description of Legal Services
Date Name Hours Description
10/04/24 Dan O'Connor 0.40 Correspond with Company and AlixPartners
re cure costs.
10/10/24 Sabrina Lieberman 0.10 Correspond with C. Ceresa, Cole Schotz,
contract counterparty re assumption and
assignment of contract.
Total 0.50
3
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 55 of 95
601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
December 6, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050108828
Client Matter: 48520-12
In the Matter of Business Operations
For legal services rendered through October 31, 2024
(see attached Description of Legal Services for detail) $ 30,992.50
Total legal services rendered $ 30,992.50
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 56 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108828
Vyaire Medical Inc. Matter Number: 48520-12
Business Operations
Summary of Hours Billed
Name Hours Rate Amount
Chris Ceresa 0.30 1,395.00 418.50
Hannah Crawford 14.30 1,595.00 22,808.50
Kate Hardey 2.50 1,995.00 4,987.50
Sabrina Lieberman 0.80 975.00 780.00
Cristina Weidner 1.20 1,665.00 1,998.00
TOTALS 19.10 $ 30,992.50
2
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 57 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108828
Vyaire Medical Inc. Matter Number: 48520-12
Business Operations
Description of Legal Services
Date Name Hours Description
06/12/24 Cristina Weidner 1.20 Telephone conference with A. Ziegler, K&E
team re liquidity planning for Germany.
10/01/24 Hannah Crawford 0.20 Review, analyze issues re Italy bankruptcy
counsel.
10/01/24 Kate Hardey 1.00 Prepare for telephone conference with FDA re
product imports (.1); telephone conference
with FDA re same (.4); review and revise
summary presentation re same (.5).
10/02/24 Hannah Crawford 1.80 Review, analyze issues re Italian operations
(1.5); correspond with S. Lieberman re same
(.3).
10/02/24 Kate Hardey 1.00 Review and comment on FDA meeting
minutes (.3); review, analyze draft
undisclosed agent agreement (.2); review,
analyze correspondence with Company re
same (.4); correspond with Company re same
(.1).
10/03/24 Hannah Crawford 5.70 Telephone conference with S. Davies (.5);
review, analyze issues re Italian law
considerations (2.0); review, analyze issues re
antitrust analysis (.5); correspond with
Company re court summons (.5); correspond
with Company re RDx entity (.5); review,
analyze issues re audit of financial statements
(.3); correspond with S. Schwander re FDI
filing (.5); correspond with S. Lieberman re
Italian operations (.4); telephone conference
with S. Toth re Italian operations (.5).
10/04/24 Hannah Crawford 0.50 Correspond with A. Schwander re FDI filing.
10/07/24 Hannah Crawford 1.50 Correspond with S. Ullathorne and P. Kar re
annual accounts overdue letter (.5);
correspond with Company re filing accounts
(.5); correspond with Company re position
(.5).
3
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 58 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108828
Vyaire Medical Inc. Matter Number: 48520-12
Business Operations
Date Name Hours Description
10/08/24 Hannah Crawford 2.80 Telephone conference with Company re
foreign entity issue (.5); telephone conference
with Company re Basingstoke (.5);
correspond with S. Winters, K&E team re
Vyaire Medical Products Limited (.5);
correspond with Company re same (.5); draft
notice (.5); correspond with Company re
Singapore entity (.3).
10/08/24 Kate Hardey 0.50 Review and revise FDA meeting minutes (.3);
correspond with Company re same (.2).
10/11/24 Chris Ceresa 0.30 Review, analyze legal issues re Korean
counsel.
10/17/24 Sabrina Lieberman 0.10 Correspond with Y. Salloum and C. Ceresa re
ordinary course professional list.
10/18/24 Hannah Crawford 0.60 Correspond with Company re Italian counsel
(.2); correspond with D. O’Connor re Italian
counsel (.2); correspond with S. Toth and D.
O’Connor re Italian counsel (.2).
10/21/24 Sabrina Lieberman 0.70 Conference with Cole Schotz re Korean
counsel (.1); correspond with Y. Salloum, C.
Ceresa, Cole Schotz, AlixPartners re same
(.6).
10/22/24 Hannah Crawford 0.40 Correspond with Y. Salloum and D.
O’Connor re tender notifications (.2);
correspond with Legance re Italian counsel
assistance (.2).
10/23/24 Hannah Crawford 0.60 Correspond with L. Finn re Italy tender
notifications (.2); correspond with Y. Salloum
re same (.2); correspond with Company re
Italian counsel (.2).
10/24/24 Hannah Crawford 0.20 Correspond with Legance re engagement
letter for Italian counsel.
Total 19.10
4
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 59 of 95
601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
December 6, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050108830
Client Matter: 48520-18
In the Matter of Insurance and Surety Matters
For legal services rendered through October 31, 2024
(see attached Description of Legal Services for detail) $ 36,987.50
Total legal services rendered $ 36,987.50
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 60 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108830
Vyaire Medical Inc. Matter Number: 48520-18
Insurance and Surety Matters
Summary of Hours Billed
Name Hours Rate Amount
Michael Ehret 17.80 1,895.00 33,731.00
Emanuel Goetz 0.50 750.00 375.00
William T. Pruitt 1.70 1,695.00 2,881.50
TOTALS 20.00 $ 36,987.50
2
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 61 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108830
Vyaire Medical Inc. Matter Number: 48520-18
Insurance and Surety Matters
Description of Legal Services
Date Name Hours Description
10/01/24 Michael Ehret 0.50 Review, analyze insurance coverage status
(.3); correspond with S. Toth re same, status
(.2).
10/07/24 Michael Ehret 0.30 Analyze insurance policy, next steps (.1);
correspond with Company re same (.2).
10/08/24 Michael Ehret 0.30 Correspond with Company re insurance
policy, status.
10/09/24 Michael Ehret 0.70 Correspond with Deloitte, TML re insurance
update.
10/10/24 Michael Ehret 1.50 Correspond with Company re insurance
negotiation (.5); prepare for same (.8);
analyze correspondence from Deloitte re
insurance (.2).
10/13/24 Michael Ehret 1.50 Telephone conference with Marsh re
insurance policy comments, fair market value
representation and transfer of MIM (1.0);
follow up telephone conference with Marsh re
same (.5).
10/14/24 Michael Ehret 2.20 Telephone conference with Company re
insurance coverage status, fair market value
determination, next steps (1.1); correspond
with Company re same (.5); analyze
correspondence re Trudell, insurance status
(.6).
10/15/24 Michael Ehret 1.30 Telephone conference with S. Winters, K&E
team, PJT, Company re insurance policy, fair
market value determination.
10/16/24 William T. Pruitt 0.40 Analyze issues re director appointment and
related D&O insurance issues (.2); correspond
with C. Ceresa re same (.2).
10/18/24 Michael Ehret 0.60 Telephone conference with E. Goetz, K&E
team re insurance updates.
10/22/24 Michael Ehret 1.80 Telephone conference with Company, Y.
Salloum, K&E team re fair market value
determinations re MIM transfer,
representation letter re insurance, next steps
(.5); correspond with E. Goetz re same,
memorandum (.2); telephone conference with
E. Goetz re same (.3); follow up telephone
conference with Company, Y. Salloum, K&E
team re Trudell, next steps (.8).
3
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 62 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108830
Vyaire Medical Inc. Matter Number: 48520-18
Insurance and Surety Matters
Date Name Hours Description
10/22/24 Emanuel Goetz 0.50 Telephone conference with M. Ehret, K&E
team, Company re representation letter re
insurance coverage, next steps.
10/22/24 William T. Pruitt 0.30 Analyze issues re scope of coverage for
certain individuals under D&O policy (.1);
review policies re same (.1); correspond with
Y. Salloum re same (.1).
10/23/24 Michael Ehret 0.80 Telephone conference with C. Weidner, K&E
team re tax issues re insurance.
10/23/24 William T. Pruitt 0.60 Analyze issues re scope of coverage under
D&O policies for insured persons (.3); review
D&O insurance policies re same (.2);
correspond with Marsh and Y. Salloum re
same (.1).
10/24/24 Michael Ehret 2.60 Telephone conference with Y. Salloum, K&E
team, Company re insurance coverage,
representation letter (1.0); draft agenda,
representation letter, shareholders resolution
(1.6).
10/28/24 Michael Ehret 0.40 Correspond with PwC re draft memorandum,
insurance policy.
10/29/24 Michael Ehret 1.10 Telephone conference with Company, Y.
Salloum, K&E team re insurance policy,
Trudell (.6); revise draft insurance policy (.5).
10/31/24 Michael Ehret 2.20 Telephone conference with Marsh re
insurance, MIM memorandum (.8);
correspond with Company re same, next steps
(.2); draft comments re insurance policy (1.2).
10/31/24 William T. Pruitt 0.40 Analyze insurance and indemnification issues
(.3); correspond with Y. Salloum re same (.1).
Total 20.00
4
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 63 of 95
601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
December 6, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050108831
Client Matter: 48520-20
In the Matter of Tax Matters
For legal services rendered through October 31, 2024
(see attached Description of Legal Services for detail) $ 150,356.00
Total legal services rendered $ 150,356.00
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 64 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108831
Vyaire Medical Inc. Matter Number: 48520-20
Tax Matters
Summary of Hours Billed
Name Hours Rate Amount
Hannah Crawford 0.60 1,595.00 957.00
Michael Ehret 33.60 1,895.00 63,672.00
Emanuel Goetz 14.80 750.00 11,100.00
Palmer Gunderson 33.10 995.00 32,934.50
Sabrina Lieberman 0.20 975.00 195.00
Nicholas Warther 14.70 1,665.00 24,475.50
Cristina Weidner 2.00 1,665.00 3,330.00
Sara B. Zablotney, P.C. 5.60 2,445.00 13,692.00
TOTALS 104.60 $ 150,356.00
2
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 65 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108831
Vyaire Medical Inc. Matter Number: 48520-20
Tax Matters
Description of Legal Services
Date Name Hours Description
06/25/24 Cristina Weidner 2.00 Telephone conference with M. Ehret, K&E
team re German tax structuring.
10/01/24 Michael Ehret 0.20 Correspond with S. Toth, K&E team,
Company advisors re novation agreement,
comments.
10/01/24 Palmer Gunderson 2.90 Telephone conference with Company re tax
planning for transfer of subsidiaries (.8);
prepare tax comments on amendment to
purchase agreement (1.5); correspond with N.
Warther, K&E team re tax planning for
transferred subsidiaries (.6).
10/01/24 Sabrina Lieberman 0.10 Correspond with Cole Schotz re IRS
correspondence.
10/01/24 Nicholas Warther 1.10 Telephone conference with BDO, S. Toth,
K&E team re tax analysis of Zoll transaction
(.6); correspond with S. Toth, K&E team re
same (.5).
10/01/24 Sara B. Zablotney, P.C. 1.20 Review, analyze Zoll structure information
(.3); telephone conference with S. Toth, K&E
team re same (.5) correspond with S. Toth,
K&E team re intercompany issues (.4).
10/02/24 Michael Ehret 1.10 Correspond with Company re FMV
determination for disposal of shares, novation
settlement agreement (.6); analyze
correspondence re German tax implications
upon set-off (.5).
10/02/24 Palmer Gunderson 4.50 Prepare tax comments to purchase agreement
amendment (1.8); revise purchase price
allocation for sale transaction (.5); revise
intended tax treatment language for settlement
agreement (.4); correspond M. Ehret, K&E
team re settlement agreement (.7); analyze
regulations and compliance rules for tax
election (1.1).
10/02/24 Nicholas Warther 1.00 Review and analyze tax portions of
intercompany settlement agreement (.4);
review and revise Zoll APA (.6).
3
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 66 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108831
Vyaire Medical Inc. Matter Number: 48520-20
Tax Matters
Date Name Hours Description
10/03/24 Palmer Gunderson 1.60 Telephone conference with N. Warther, K&E
team re settlement agreement (.4); review,
analyze comments to settlement agreement
(.3); correspond with N. Warther, K&E team
re tax treatment of settlement agreement (.6);
correspond with Company, N. Warther, K&E
team re revised purchase price allocation (.3).
10/03/24 Sara B. Zablotney, P.C. 0.70 Correspond with N. Warther, K&E team re
intercompany issues (.6); correspond with N.
Warther, K&E team re intended tax treatment
(.1).
10/04/24 Michael Ehret 1.70 Draft VAT clause (.5); correspond with C.
Paus re same (.3); telephone conference with
C. Paus re same (.2); correspond with S.
Zablotney, K&E team re BDO US comments,
issues (.4); correspond with S. Zablotney,
K&E team re novation and set-off agreement
(.3).
10/04/24 Palmer Gunderson 1.10 Finalize, revise purchase price allocation with
tax and company (.2); prepare tax forms for
tax elections (.9).
10/04/24 Sara B. Zablotney, P.C. 0.60 Correspond with N. Warther, K&E team re
financial statements (.3); review, analyze PPA
(.3).
10/05/24 Palmer Gunderson 2.40 Correspond with N. Warther, K&E team re
tax planning for sale transaction (.4); prepare
tax forms for sale transaction (1.6);
correspond with N. Warther, K&E team re
settlement agreement (.4).
10/05/24 Nicholas Warther 0.80 Review and revise agency agreement (.6);
correspond with P. Gunderson, K&E team re
same (.2).
10/06/24 Nicholas Warther 1.00 Review and analyze tax portions of agency
agreement.
10/07/24 Nicholas Warther 0.60 Review and revise tax portions of agency
agreement.
10/08/24 Palmer Gunderson 0.80 Analyze and prepare tax comments on
settlement agreement.
10/08/24 Nicholas Warther 0.30 Correspond with P. Gunderson, K&E team re
tax structuring.
4
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 67 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108831
Vyaire Medical Inc. Matter Number: 48520-20
Tax Matters
Date Name Hours Description
10/09/24 Michael Ehret 1.50 Telephone conference with Company re tax
return filing, novation settlement agreement
(1.0); draft overview re fair market value
determination (.5).
10/09/24 Palmer Gunderson 4.40 Correspond with N. Warther, K&E team re
company tax diligence items (.3); analyze and
prepare tax comments on updated settlement
agreement (2.1); telephone conference with
N. Warther, K&E team re restructuring
transactions and tax treatment of settlement
agreement (.2); draft correspondence re tax
treatment and structure of settlement
agreement (1.8).
10/09/24 Nicholas Warther 1.40 Review and revise intercompany settlement
(.8); correspond with P. Gunderson, K&E
team re same (.6).
10/10/24 Michael Ehret 3.20 Correspond with C. Paus, K&E team re VAT
clause updates, open tax items re sale, APA
(2.0); correspond with Company re same, tax
analysis, tax exposure calculation (1.2).
10/10/24 Palmer Gunderson 0.80 Review, analyze draft tax forms for tax
election.
10/10/24 Nicholas Warther 2.70 Review and revise intercompany settlement
agreement (1.4); correspond with Company re
same (.6); review and analyze 338 elections
(.7).
10/10/24 Sara B. Zablotney, P.C. 0.40 Participate in telephone conference with S.
Toth, K&E team re intercompany issues.
10/11/24 Michael Ehret 2.80 Telephone conference with Deloitte, TML re
technical arguments re insurance coverage
(1.0); draft correspondence to Deloitte re
same (.5); telephone conference with
Company re same, next steps (1.0); telephone
conference with Deloitte re same (.3).
10/14/24 Emanuel Goetz 0.60 Review, analyze envisaged tax insurance.
10/16/24 Michael Ehret 2.50 Telephone conference with Company re off-
setting receivables, tax implications and fair
market value determinations (.5); telephone
conference with E. Goetz re Trudell
transaction, tax issues, next steps (.8); draft
presentation re same (.9); correspond with
Company, E. Goetz, K&E team re same (.3).
10/16/24 Emanuel Goetz 0.80 Telephone conference with M. Ehret, K&E
team re tax implications re Trudell.
5
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 68 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108831
Vyaire Medical Inc. Matter Number: 48520-20
Tax Matters
Date Name Hours Description
10/16/24 Palmer Gunderson 1.50 Analyze tax consequences of settlement of
intercompany obligations for sale transaction.
10/17/24 Hannah Crawford 0.30 Telephone conference with AlixPartners re
Basingstoke taxes.
10/17/24 Hannah Crawford 0.30 Correspond with S. Toth and AlixPartners re
tax issue.
10/17/24 Emanuel Goetz 0.80 Review and revise set off analysis re Vyaire
GmbH.
10/17/24 Palmer Gunderson 1.90 Analyze and prepare tax comments on
purchase agreement (1.1); correspond with N.
Warther, K&E team re tax planning for sale
transaction (.8).
10/17/24 Nicholas Warther 0.30 Review and analyze issues re Brazil
intercompany.
10/17/24 Sara B. Zablotney, P.C. 0.50 Telephone conference with M. Ehret, K&E
team re tax insurance.
10/18/24 Michael Ehret 3.50 Telephone conference with Company re MIM
transfer, fair market value determination
(1.0); correspond with Company re same
(1.0); telephone conference with Deloitte re
open tax items (.8); correspond with Deloitte
re same (.2); analyze Deloitte correspondence
re same (.5).
10/18/24 Emanuel Goetz 0.60 Telephone conference with M. Ehret, K&E
team, Company re insurance for Vyaire
Medical GmbH.
10/18/24 Emanuel Goetz 0.80 Telephone conference with M. Ehret and
Deloitte re open topics re tax insurance for
Vyaire Medical GmbH.
10/18/24 Emanuel Goetz 0.30 Review and revise tax insurance for VMG.
10/18/24 Palmer Gunderson 1.00 Correspond with E. Goetz, K&E team re tax
planning for sale transaction.
10/18/24 Sara B. Zablotney, P.C. 0.80 Analyze Brazil receivable (.4); correspond
with P. Gunderson, K&E team re same (.1);
analyze Brazil cancellation (.3).
10/19/24 Michael Ehret 2.70 Telephone conference with Y. Salloum, K&E
team, Company re insurance, tax structure,
next steps (.5); analyze Marsh correspondence
re same (.3); telephone conference with
Marsh re same (.7); telephone conference
with Trudell, Deloitte, Marsh re alternative
structures (1.0); correspond with Company re
same (.2).
6
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 69 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108831
Vyaire Medical Inc. Matter Number: 48520-20
Tax Matters
Date Name Hours Description
10/19/24 Palmer Gunderson 0.30 Correspond with N. Warther, S. Zablotney
and BDO re tax planning for sale transaction.
10/19/24 Sara B. Zablotney, P.C. 0.20 Correspond with P. Gunderson, K&E team re
Brazil agreement.
10/20/24 Palmer Gunderson 1.10 Review, analyze purchase agreement (.9);
correspond with N. Warther and S. Zablotney
re tax issues in purchase agreement (.2).
10/20/24 Sabrina Lieberman 0.10 Correspond with Cole Schotz re open tax
items.
10/21/24 Palmer Gunderson 0.50 Correspond with N. Warther, S. Zablotney,
and BDO re tax planning for sale transaction.
10/21/24 Sara B. Zablotney, P.C. 0.20 Correspond with N. Warther, K&E team re
Brazil sale transaction.
10/22/24 Michael Ehret 0.70 Telephone conference with Company re
German tax implications.
10/22/24 Emanuel Goetz 1.20 Telephone conference with Company, S.
Toth, K&E team re tax issues re insurance
(.9); telephone conference with M. Ehret re
same (.3).
10/22/24 Emanuel Goetz 0.30 Analyze issues, strategy re MIM valuation.
10/22/24 Palmer Gunderson 1.50 Review and analyze tax issues in plan
supplement (.9); telephone conference with S.
Liberman re plan supplement (.2); correspond
with N. Warther and S. Zablotney re same
(.4).
10/22/24 Nicholas Warther 0.60 Correspond with P. Gunderson, K&E team re
wind-down documentation.
10/23/24 Michael Ehret 1.60 Telephone conference with PwC, Company,
E. Goetz re MIM transfer (.4); telephone
conference with Y. Salloum, K&E team,
Company re next steps, tax implications (.5);
correspond with S. Toth, K&E team re same
(.7).
10/23/24 Emanuel Goetz 0.80 Telephone conference with M. Ehret, K&E
team re next steps for receiving tax insurance.
10/23/24 Emanuel Goetz 0.40 Telephone conference with C. Paus, K&E
team re German implications of share transfer
in MIM.
10/23/24 Palmer Gunderson 3.10 Review and prepare tax comments on
purchase agreement (2.9); correspond with N.
Warther and S. Zablotney re same (.2).
7
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 70 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108831
Vyaire Medical Inc. Matter Number: 48520-20
Tax Matters
Date Name Hours Description
10/24/24 Emanuel Goetz 0.50 Analyze spreadsheet re valuation of MIM
Medizinische Monitoring und Instrumente
GmbH.
10/24/24 Nicholas Warther 1.30 Review and analyze tax structuring and
documentation (.8); correspond with Y.
Salloum, K&E team re same (.5).
10/25/24 Michael Ehret 1.20 Telephone conference with PwC re MIM
transfer analysis, shareholder update, tax
implications (.7); correspond with various
parties re shareholder resolution, agenda (.5).
10/25/24 Emanuel Goetz 2.50 Draft summary of German tax implications re
MIM sale.
10/27/24 Michael Ehret 2.80 Review, analyze draft memorandum re MIM
transfer, German tax implications (2.5);
correspond with Company, E. Goetz re same
(.3).
10/28/24 Michael Ehret 3.00 Analyze structure memorandum re MIM,
purchase price determination (.9); telephone
conference with PwC re tax structuring
considerations, shareholder meeting (.4); draft
and revise tax memorandum (1.7).
10/28/24 Emanuel Goetz 1.50 Review and revise draft summary of German
tax implications re MIM transfer.
10/28/24 Palmer Gunderson 2.10 Telephone conference with N. Warther, S.
Zablotney, BDO, Company re wind down tax
planning (1.0); correspond with N. Warther,
K&E team re tax planning for sale transaction
(.2); revise tax comments on purchase
agreement (.5); telephone conference with N.
Warther and S. Zablotney re wind down tax
planning (.4).
10/28/24 Nicholas Warther 2.10 Telephone conference with BDO re tax
analysis (1.0); review and analyze structuring
(1.1).
10/28/24 Sara B. Zablotney, P.C. 1.00 Telephone conference re wind down with N.
Warther, K&E team (.5); telephone
conference with Company re same, BDO (.5).
10/29/24 Michael Ehret 1.50 Telephone conference with E. Goetz, K&E
team, Company re tax implications re MIM
transfer (.5); analyze, draft memorandum re
MIM transfer (.8); correspond with Company
re same (.2).
8
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 71 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108831
Vyaire Medical Inc. Matter Number: 48520-20
Tax Matters
Date Name Hours Description
10/29/24 Emanuel Goetz 0.50 Telephone conference with Company, Y.
Salloum, K&E team re tax implications re
MIM transfer.
10/29/24 Emanuel Goetz 1.20 Review and revise tax insurance draft for
Vyaire Medical GmbH.
10/29/24 Emanuel Goetz 1.00 Review and revise summary draft re German
tax implications summary re MIM transfer.
10/29/24 Emanuel Goetz 1.00 Draft summary re German tax implications
summary re MIM transfer.
10/29/24 Palmer Gunderson 1.60 Research and prepare summary of tax
treatment of worthless stock deductions in
context of ownership change rules (.6);
telephone conference with S. Zablotney, N.
Warther, Company and BDO re wind-down
tax planning (.8); prepare for same (.2).
10/29/24 Nicholas Warther 0.80 Telephone conference with P. Gunderson,
BDO, Company re wind-down tax
structuring.
10/30/24 Michael Ehret 1.50 Analyze intra-group share transfer
memorandum (.6); correspond with Company
re same (.5); correspond with Marsh re
memorandum re MIM transfer (.4).
10/31/24 Michael Ehret 2.10 Telephone conference with Company re
reconciliation numbers (.6); correspond with
Company, Y. Salloum, K&E team re same
(.4); review, revise draft SPA re MIM transfer
(.6); telephone conference with C. Paus, K&E
team re purchase price clause, set-off (.5).
10/31/24 Nicholas Warther 0.70 Review and revise tax portions of Blender
APA.
Total 104.60
9
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 72 of 95
601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
December 6, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050108832
Client Matter: 48520-21
In the Matter of Case Administration
For legal services rendered through October 31, 2024
(see attached Description of Legal Services for detail) $ 12,220.50
Total legal services rendered $ 12,220.50
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 73 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108832
Vyaire Medical Inc. Matter Number: 48520-21
Case Administration
Summary of Hours Billed
Name Hours Rate Amount
Chris Ceresa 0.20 1,395.00 279.00
Tiffani Chanroo 0.50 1,345.00 672.50
Hannah Crawford 0.20 1,595.00 319.00
Sabrina Lieberman 6.30 975.00 6,142.50
Josh Sussberg, P.C. 0.10 2,305.00 230.50
Steve Toth 1.60 1,820.00 2,912.00
Cristina Weidner 1.00 1,665.00 1,665.00
TOTALS 9.90 $ 12,220.50
2
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 74 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108832
Vyaire Medical Inc. Matter Number: 48520-21
Case Administration
Description of Legal Services
Date Name Hours Description
08/14/24 Cristina Weidner 1.00 Attend telephone conference re current status,
correspondence.
10/01/24 Tiffani Chanroo 0.50 Correspond with J. Foster, K&E team re
cancelled hearing (.1); review, analyze
correspondence re case status (.4).
10/04/24 Steve Toth 0.50 Discuss open bankruptcy issues and case
status with Cole Schotz, Y. Salloum, K&E
team and AlixPartners.
10/11/24 Josh Sussberg, P.C. 0.10 Correspond with S. Winters re case status.
10/17/24 Sabrina Lieberman 0.30 Conference with Y. Salloum, K&E team,
AlixPartners re work in process.
10/17/24 Steve Toth 0.60 Correspond with Cole Schotz, AlixPartners,
Y. Salloum, K&E team re case updates.
10/18/24 Sabrina Lieberman 0.40 Conference with Y. Salloum, K&E team,
AlixPartners re work in process.
10/18/24 Steve Toth 0.50 Correspond with Cole Schotz, Y. Salloum,
K&E team re case update.
10/21/24 Sabrina Lieberman 0.70 Conference with Y. Salloum, Cole Schotz,
AlixPartners re work in process.
10/22/24 Sabrina Lieberman 1.10 Conference with Y. Salloum, AlixPartners,
Cole Schotz re work in process.
10/23/24 Sabrina Lieberman 0.70 Conference with Y. Salloum, S. Toth,
AlixPartners, Cole Schotz re work in process.
10/24/24 Hannah Crawford 0.20 Correspond with Legance re case status.
10/24/24 Sabrina Lieberman 0.50 Conference with Y. Salloum, K&E team,
AlixPartners re work in process.
10/25/24 Sabrina Lieberman 0.80 Conference with Y. Salloum, Cole Schotz,
AlixPartners re work in process (.6); draft
weekly internal memorandum (.2).
10/28/24 Sabrina Lieberman 0.10 Conference with Y. Salloum, AlixPartners re
work in process.
10/29/24 Sabrina Lieberman 0.70 Conference with Y. Salloum, Cole Schotz,
AlixPartners re work in process (.6);
correspond with Y. Salloum, K&E team re
same (.1).
10/30/24 Sabrina Lieberman 0.40 Correspond with Y. Salloum, K&E team re
work in process.
10/31/24 Chris Ceresa 0.20 Correspond with Company re operations.
3
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 75 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108832
Vyaire Medical Inc. Matter Number: 48520-21
Case Administration
Date Name Hours Description
10/31/24 Sabrina Lieberman 0.60 Conference with Y. Salloum, Cole Schotz,
AlixPartners re work in process.
Total 9.90
4
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 76 of 95
601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
December 6, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050108833
Client Matter: 48520-22
In the Matter of Retention - K&E
For legal services rendered through October 31, 2024
(see attached Description of Legal Services for detail) $ 52,661.50
Total legal services rendered $ 52,661.50
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 77 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108833
Vyaire Medical Inc. Matter Number: 48520-22
Retention - K&E
Summary of Hours Billed
Name Hours Rate Amount
Chris Ceresa 9.40 1,395.00 13,113.00
Tiffani Chanroo 14.60 1,345.00 19,637.00
Susan D. Golden 0.50 1,600.00 800.00
Sabrina Lieberman 17.70 975.00 17,257.50
Josh Sussberg, P.C. 0.10 2,305.00 230.50
Spencer A. Winters, P.C. 0.50 1,685.00 842.50
Tanzila Zomo 2.20 355.00 781.00
TOTALS 45.00 $ 52,661.50
2
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 78 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108833
Vyaire Medical Inc. Matter Number: 48520-22
Retention - K&E
Description of Legal Services
Date Name Hours Description
10/01/24 Chris Ceresa 2.80 Review, revise K&E fee statement for
privilege and confidentiality issues (2.5);
correspond with S. Lieberman and K&E team
re same (.3).
10/01/24 Sabrina Lieberman 0.50 Review, revise supplemental declaration in
support of K&E retention.
10/02/24 Sabrina Lieberman 0.20 Review, revise second supplemental
declaration in support of K&E retention.
10/03/24 Chris Ceresa 2.60 Review, revise K&E fee statement for
privilege and confidentiality issues (2.4);
correspond with S. Lieberman and K&E team
re same (.2).
10/03/24 Tiffani Chanroo 0.80 Review, revise monthly fee statement re
privilege, confidentiality.
10/03/24 Sabrina Lieberman 2.10 Review, revise July monthly fee statement
(.6); review, revise declaration in support of
K&E retention (1.5).
10/03/24 Spencer A. Winters, P.C. 0.50 Review, revise K&E fee application.
10/04/24 Chris Ceresa 1.90 Review, revise K&E fee statement for
privilege and confidentiality issues (1.7);
correspond with S. Lieberman and K&E team
re same (.2).
10/04/24 Tiffani Chanroo 1.40 Review, revise interim fee statement re
privilege, confidentiality.
10/07/24 Sabrina Lieberman 0.10 Correspond with C. Ceresa, K&E team re
K&E fee application.
10/09/24 Chris Ceresa 0.80 Correspond with S. Lieberman and K&E team
re K&E fee statement issues.
10/09/24 Tanzila Zomo 2.20 Review, revise fee statement re
confidentiality issues (1.9); correspond with
S. Lieberman re same (.3).
10/10/24 Tiffani Chanroo 0.60 Review, analyze K&E interim fee application.
10/10/24 Sabrina Lieberman 0.20 Correspond with C. Ceresa, T. Chanroo re
interim fee application.
10/11/24 Tiffani Chanroo 0.20 Review, analyze correspondence from S.
Lieberman re K&E fee application.
10/11/24 Sabrina Lieberman 0.50 Conference with C. Ceresa, K&E team re
interim fee application.
3
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 79 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108833
Vyaire Medical Inc. Matter Number: 48520-22
Retention - K&E
Date Name Hours Description
10/13/24 Sabrina Lieberman 2.80 Review, revise invoice re confidentiality and
privilege considerations.
10/14/24 Sabrina Lieberman 2.50 Review, revise invoice re privilege,
confidentiality.
10/21/24 Chris Ceresa 0.10 Correspond with Y. Salloum and S.
Lieberman re K&E retention items.
10/21/24 Chris Ceresa 0.20 Correspond with S. Lieberman, K&E team re
K&E retention legal issues.
10/22/24 Sabrina Lieberman 0.80 Review, revise September invoice re
privilege, confidentiality.
10/22/24 Josh Sussberg, P.C. 0.10 Correspond with S. Winters re fee auditor.
10/24/24 Tiffani Chanroo 4.90 Review, revise K&E invoice for privilege and
confidentiality.
10/25/24 Sabrina Lieberman 3.20 Review, revise September invoice re
privilege, confidentiality (2.7); correspond
with S. Toth, K&E team re same (.5).
10/28/24 Tiffani Chanroo 0.20 Correspond with S. Lieberman re interim fee
application.
10/28/24 Susan D. Golden 0.50 Conference with fee examiner, Cole Schotz,
Y. Salloum re fee examiner appointment and
fee examiner expectations (.3); correspond
with C. Ceresa, K&E team re interim fee
application (.2).
10/28/24 Sabrina Lieberman 0.20 Correspond with Y. Salloum, K&E team re
interim fee application.
10/29/24 Chris Ceresa 0.20 Correspond with S. Lieberman, K&E team re
K&E retention.
10/29/24 Tiffani Chanroo 0.10 Correspond with S. Lieberman re interim fee
application.
10/30/24 Tiffani Chanroo 4.20 Review, analyze interim fee application (3.9);
correspond with S. Lieberman re same (.3).
10/31/24 Chris Ceresa 0.80 Correspond with S. Lieberman, K&E team re
K&E retention.
10/31/24 Tiffani Chanroo 2.20 Review, revise interim fee application (1.9);
correspond with S. Lieberman re same (.3).
10/31/24 Sabrina Lieberman 4.60 Conference with S. Winters, Y. Salloum,
AlixPartners re K&E fee application (.5);
correspond with U.S. Trustee re same (.1);
review, revise certification of counsel (.2);
correspond with C. Ceresa, AlixPartners, Cole
Schotz re same (.2); review, revise interim fee
application (3.6).
4
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 80 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108833
Vyaire Medical Inc. Matter Number: 48520-22
Retention - K&E
Total 45.00
5
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 81 of 95
601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
December 6, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050108836
Client Matter: 48520-26
In the Matter of Expenses
For expenses incurred through October 31, 2024
(see attached Description of Expenses for detail) $ 3,957.43
Total expenses incurred $ 3,957.43
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 82 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108836
Vyaire Medical Inc. Matter Number: 48520-26
Expenses
Description of Expenses
Description Amount
Standard Copies or Prints 16.30
Color Copies or Prints 50.60
Local Transportation 254.13
Travel Expense 360.80
Airfare 1,556.62
Transportation to/from airport 324.35
Travel Meals 178.00
Outside Retrieval Service 1.83
Computer Database Research 23.76
Westlaw Research 729.90
LexisNexis Research 131.05
Overtime Transportation 234.22
Overtime Meals - Attorney 95.87
Total $ 3,957.43
2
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 83 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108836
Vyaire Medical Inc. Matter Number: 48520-26
Expenses
Description of Expenses
Standard Copies or Prints
Date Description Amount
10/01/24 Standard Copies or Prints 0.10
10/02/24 Standard Copies or Prints 0.20
10/02/24 Standard Copies or Prints 0.40
10/08/24 Standard Copies or Prints 0.10
10/09/24 Standard Copies or Prints 0.40
10/10/24 Standard Copies or Prints 0.10
10/22/24 Standard Copies or Prints 0.50
10/23/24 Standard Copies or Prints 8.30
10/24/24 Standard Copies or Prints 0.10
10/29/24 Standard Copies or Prints 0.40
10/31/24 Standard Copies or Prints 5.70
Total 16.30
3
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 84 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108836
Vyaire Medical Inc. Matter Number: 48520-26
Expenses
Color Copies or Prints
Date Description Amount
10/02/24 Color Copies or Prints 9.90
10/03/24 Color Copies or Prints 1.10
10/08/24 Color Copies or Prints 2.20
10/09/24 Color Copies or Prints 12.10
10/16/24 Color Copies or Prints 3.30
10/23/24 Color Copies or Prints 7.70
10/28/24 Color Copies or Prints 12.10
10/29/24 Color Copies or Prints 2.20
Total 50.60
4
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 85 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108836
Vyaire Medical Inc. Matter Number: 48520-26
Expenses
Local Transportation
Date Description Amount
08/29/24 Spencer A. Winters, P.C., Taxi, home from hearing 08/29/2024 87.04
09/13/24 VITAL TRANSPORTATION SERVICES INC - Zomo Tanzila - 122.36
home from hearing 08/30/2024
10/03/24 Hannah Crawford - Taxi home from working late 10/03/2024 44.73
Total 254.13
5
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 86 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108836
Vyaire Medical Inc. Matter Number: 48520-26
Expenses
Travel Expense
Date Description Amount
08/26/24 Tabitha J. De Paulo, Lodging, Wilmington, DE, Travel to 174.90
Wilmington, DE. 08/26/2024
08/30/24 Tabitha J. De Paulo - Lodging, Wilmington, DE, Travel to 185.90
Wilmington, DE. 08/30/2024
Total 360.80
6
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 87 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108836
Vyaire Medical Inc. Matter Number: 48520-26
Expenses
Airfare
Date Description Amount
08/21/24 Tabitha J. De Paulo, Airfare (coach), from Chicago, IL to 678.94
Philadelphia, PA, 08/25/2024
08/26/24 Tabitha J. De Paulo - Airfare (coach), from Philadelphia, PA to 320.08
Chicago, IL, 08/27/2024
08/27/24 Tabitha J. De Paulo - Airfare (flight change), from Philadelphia, 103.60
PA to Chicago, IL, 08/27/2024
08/28/24 Tabitha J. De Paulo - Airfare (coach), round trip, Chicago, 454.00
IL/Philadelphia, PA, 08/28/2024-08/29/2024
Total 1,556.62
7
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 88 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108836
Vyaire Medical Inc. Matter Number: 48520-26
Expenses
Transportation to/from airport
Date Description Amount
09/26/24 SUNNY'S WORLDWIDE - 09/18/2024 WINTERS SPENCER 143.00
Pick Up at PHL Airport and Drop Off at Hotel
09/26/24 SUNNY'S WORLDWIDE - 09/19/2024 WINTERS SPENCER 181.35
Pick Up at Hotel and Drop Off at PHL Airport
Total 324.35
8
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 89 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108836
Vyaire Medical Inc. Matter Number: 48520-26
Expenses
Travel Meals
Date Description Amount
08/25/24 Tabitha J. De Paulo, Travel Meals, Chicago, Illinois Travel to 20.00
Wilmington, Delaware. 08/25/2024
08/25/24 Spencer A. Winters, P.C. - Travel Meals, PHL hearing 08/25/2024 20.00
08/26/24 Spencer A. Winters, P.C. - Travel Meals with Tabitha J. De Paulo, 40.00
PHL hearing 08/26/2024
08/26/24 Tabitha J. De Paulo, Travel Meals, Wilmington, Delaware Travel 18.00
to Wilmington, Delaware. 08/26/2024
08/28/24 Tabitha J. De Paulo - Travel Meals, Chicago, Illinois Travel to 20.00
Wilmington, Delaware 08/28/2024
08/29/24 Tabitha J. De Paulo - Travel Meals, Wilmington, Delaware Travel 20.00
to Wilmington, Delaware 08/29/2024
08/29/24 Spencer A. Winters, P.C. - Travel Meals, Chicago hearing 20.00
08/29/2024
08/30/24 Tabitha J. De Paulo - Travel Meals, Philadelphia, Pennsylvania 20.00
Travel to Wilmington, Delaware 08/30/2024
Total 178.00
9
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 90 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108836
Vyaire Medical Inc. Matter Number: 48520-26
Expenses
Outside Retrieval Service
Date Description Amount
10/02/24 BUNDESANZEIGER VERLAG - Document Retrieval Service. 1.83
Total 1.83
10
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 91 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108836
Vyaire Medical Inc. Matter Number: 48520-26
Expenses
Computer Database Research
Date Description Amount
09/30/24 RELX Inc DBA LexisNexis - Courtlink Usage for 09/2024 3.76
10/22/24 RESTRUCTURING CONCEPTS LLC - Chapter 11 Dockets 20.00
Usage for 09/2024
Total 23.76
11
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 92 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108836
Vyaire Medical Inc. Matter Number: 48520-26
Expenses
Westlaw Research
Date Description Amount
09/03/24 THOMSON REUTERS - WEST PUBLISHING CORP - 24.76
WESTLAW Research Charges on 9/3/2024
09/12/24 THOMSON REUTERS - WEST PUBLISHING CORP - 265.37
WESTLAW Research Charges on 9/12/2024
09/16/24 THOMSON REUTERS - WEST PUBLISHING CORP - 278.73
WESTLAW Research Charges on 9/16/2024
09/19/24 THOMSON REUTERS - WEST PUBLISHING CORP - 112.09
WESTLAW Research Charges on 9/19/2024
10/04/24 THOMSON REUTERS - WEST PUBLISHING CORP - 48.95
WESTLAW Research Charges, 10/4/2024
Total 729.90
12
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 93 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108836
Vyaire Medical Inc. Matter Number: 48520-26
Expenses
LexisNexis Research
Date Description Amount
09/13/24 RELX Inc DBA LexisNexis - LexisNexis Research on 9/13/2024 28.88
09/25/24 RELX Inc DBA LexisNexis - LexisNexis Research on 9/25/2024 102.17
Total 131.05
13
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 94 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108836
Vyaire Medical Inc. Matter Number: 48520-26
Expenses
Overtime Transportation
Date Description Amount
09/23/24 Donatus Wang - Taxi, Overtime Transportation 09/23/2024 20.21
10/03/24 Steve Toth - Taxi, Overtime Transportation 10/03/2024 32.72
10/08/24 Steve Toth - Taxi, Overtime Transportation 10/08/2024 32.41
10/09/24 Steve Toth - Taxi, Overtime Transportation 10/09/2024 38.44
10/10/24 Steve Toth - Taxi, Overtime Transportation 10/10/2024 39.29
10/10/24 Scottie Shermetaro - Taxi, Overtime Transportation 10/10/2024 18.85
10/23/24 Steve Toth - Taxi, Overtime Transportation 10/23/2024 25.49
10/31/24 Sabrina Lieberman - Taxi, Overtime Transportation 10/31/2024 26.81
Total 234.22
14
Case 24-11217-BLS Doc 823-2 Filed 12/06/24 Page 95 of 95
Legal Services for the Period Ending October 31, 2024 Invoice Number: 1050108836
Vyaire Medical Inc. Matter Number: 48520-26
Expenses
Overtime Meals - Attorney
Date Description Amount
10/02/24 Steve Toth - Overtime Meals - Attorney, Chicago 10/02/2024 11.56
10/09/24 Steve Toth - Overtime Meals - Attorney, Chicago 10/09/2024 8.12
10/10/24 Carolin Paus – Overtime Meals – Attorney, München, Germany 16.89
19/09/2024
10/10/24 Carolin Paus – Overtime Meals – Attorney, München, Germany 20.00
16/09/2024
10/10/24 Steve Toth - Overtime Meals - Attorney, Chicago 10/10/2024 9.74
10/21/24 Paul Paefgen - Overtime Meals - Attorney, München, Germany 18.00
10/21/2024
10/23/24 Steve Toth - Overtime Meals - Attorney, Chicago 10/23/2024 11.56
Total 95.87
TOTAL EXPENSES $ 3,957.43
15
File and source
- File
- gov.uscourts.deb.193283.823.2.pdf
- Size
- 2,466,716 bytes
- SHA-256
- a74a4047929dfc646acd825d89f3a8313f3a5861c2f3f7796880444dc4a6233e
- Original
- PACER (login required)